Peer-Reviewed
Papers – 141; Books/Book and Textbook Chapters/Book Reviews – 20; Extended
Abstracts/Conference Proceedings – 64; Abstracts – 265; Patents – 8.
The papers have been cited 11217 times
(6970 times since 2012) and regularly highlighted by different sources. Hirsch
index is 51.
1.
O. B. Garbuzenko, V. Ivanova, V. Kholodovych, D. C.
Reimer, K. R. Reuhl, E. Yurkow, D. Adler, T.
Minko, Combinatorial treatment of idiopathic pulmonary fibrosis using
nanoparticles with prostaglandin E and siRNA(s), Nanomedicine, 13, 1983-1992 (2017).
PMID: 28434932.
2.
R. Savla, T.
Minko, Nanoparticle Design Considerations for Molecular Imaging of
Apoptosis: Diagnostic, Prognostic, and Therapeutic Value, Advanced Drug Delivery Reviews, 113, 122-140 (2017). PMID: 27374457.
3.
Z. R. Lu, T.
Minko, Molecular imaging for precision medicine, Advanced
Drug Delivery Reviews, 113, 1-2 (2017). PMID: 28821310.
4.
X. Li, O. Taratula, O. Taratula, C. Schumann, T. Minko, LHRH-Targeted
Drug Delivery Systems for Cancer Therapy, Mini Rev Med Chem, 17, 258-267 (2017)
PMID: 27739358.
5.
J. Sapiezynski, O. Taratula, L. Rodriguez-Rodriguez, T. Minko, Precision targeted therapy of
ovarian cancer, J Control Release, 243, 250-268 (2016) PMID: 27746277.
6.
M. Dorrani, O.B. Garbuzenko, T. Minko, B. Michniak-Kohn, Development of Edge-activated liposomes
for siRNA delivery to human basal epidermis for melanoma therapy, J Control
Release, 228,150-158 (2016) PMID: 26965957.
7.
P. T. Yin, S. Shah, N. J. Pasquale, O. B. Garbuzenko, T. Minko, K-B. Lee, Stem cell-based
gene therapy activated using magnetic hyperthermia to enhance the treatment of
cancer, Biomaterials, 81:46-57 (2016) PMID: 26720500.
8.
A. Kuzmov, T.
Minko, Nanotechnology Approaches for Inhalation Treatment of Lung Diseases,
J Control Release, 219, 500-518 (2015) PMID:
26297206.
9.
M. Shah, V. Shah, A. Ghosh, Z. Zhang, T. Minko, Molecular inclusion complexes of β-cyclodextrin
derivatives enhance aqueous solubility and cellular internalization of
paclitaxel: Preformulation and in vitro assessments, J Pharm Pharmacol., 2, 8-25
(2015) PMID: 25950011.
10.
R. N. Jain, X. Huang, S. Das, R. Silva, V. Ivanova, T. Minko, T. Asefa, Functionalized Mesoporous Silica Nanoparticles for Glucose-
and pH-Stimulated Release of Insulin, Z. Anorg. Allg. Chem. (Zeitschrift
fur anorganische und allgemeine Chemie, ZAAC, Journal of inorganic and general
chemistry), 640(3-4),
616–623 (2015).
13.
R. Savla, O. B.
Garbuzenko, S. Chen, L. Rodriguez-Rodriguez, T. Minko, Tumor-targeted responsive nanoparticle-based systems for
magnetic resonance imaging and therapy, Pharm Res, 31(12), 3487-3502 (2014)
PMID:24919932, PMCID: PMC4224753.
14.
X. Huang, Z. Tao, J.
C. Praskavich, A. Goswami, J. F. Al-Sharab, T. Minko, V. Polshettiwar, T. Asefa, Dendritic silica microspheres
(KCC-1) with fibrous pore structure possess high DNA adsorption capacity
and effectively deliver genes in vitro, Langmuir, 30(36), 10886-10898 (2014)
PMID: 25188675.
15.
X. Huang, A. Goswami,
X. Zou, S. Hayes, V. Shah, T. Minko,
Z. Tao, T. Asefa, Nanostructured TiO2 catalyzed oxidations of caffeine and
isocaffeine and their cytotoxicity and genotoxicity towards ovarian cancer
cells, BioNanoScience, 4, 27-36 (2014).
16.
R. Savla, V. Ivanova, T. Minko, Nanoparticles in the
development of therapeutic cancer vaccines, Pharmaceutical Nanotechnology, 2,
2-22 (2014).
17.
X. Xie, N. Bansal, T.
Shaik, J. E. Kerrigan, T. Minko, O.
Garbuzenko, E. E. Abali, N. Johnson-Farley, D. Banerjee, K. W. Scotto, J. R.
Bertino, A novel peptide that inhibits E2F transcription and regresses prostate
tumor xenografts, Oncotarget, 5, 901-907 (2014) PMID: 24658650, PMCID:
PMC4011592.
18.
O. B. Garbuzenko, G.
Mainelis, O. Taratula, T. Minko,
Inhalation treatment of lung cancer: the influence of composition, size and
shape of nanocarriers on their lung accumulation and retention, Cancer Biol Med,
11(1), 44-55 (2014) PMID:24738038, PMCID: PMC3969800.
19.
T. Minko, Nanotechnology
Approaches to Overcoming, Suppressing and Preventing Drug Resistance, Adv Drug
Deliv Rev, 65(13-14), 1665-1666 (2013) PMID: 24177352.
20.
T. Minko, L.
Rodriguez-Rodriguez, V. Pozharov, Nanotechnology approaches for personalized
treatment of multidrug resistant cancers, Adv Drug Deliv Rev, 65, 1880-1895 (2013)
PMID: 24120655.
21.
R. Savla, T. Minko,
Nanotechnology approaches for inhalation treatment of fibrosis, J Drug Target, 21(10),
914-925 (2013) PMID: 23978292, PMCID: PMC4219586.
22.
G. Mainelis, S.
Seshadri, O. B. Garbuzenko, Z. Wang, T.
Minko, Characterization and application of a nose-only exposure chamber for
inhalation delivery of liposomal anti-cancer drugs and nucleic acids to mice, J
Aerosol Med Pulm Drug Deliv, 26(6), 345-354 (2013) PMID: 23530772, PMCID: PMC3889495.
23.
V. Shah, O. Taratula,
O. B. Garbuzenko, O. R. Taratula, L. Rodriguez-Rodriguez, T. Minko, Targeted
Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in
Ovarian Cancer: an Optimal Delivery of siRNA and Anticancer Drug, Clin. Cancer
Res., 19(22), 6193-6204 (2013) PMID: 24036854. PMC3846837.
24.
O. Taratula, A.
Kuzmov, M. Shah, O. B. Garbuzenko, T.
Minko, Nanostructured lipid carriers as multifunctional nanomedicine
platform for pulmonary co-delivery of anticancer drugs and siRNA, J Control
Release, 171(3), 349-357 (2013) PMID: 23648833, PMCID: PMC3766401.
25.
Minko T., Hatefi A.,
Preface-tenth international nanomedicine and drug delivery symposium
(NanoDDS'12), J Control Release, 171,
259-260 (2013). PMID: 23954371.
26.
X. Xie, J. E.
Kerrigan, T. Minko, O. Garbuzenko,
K. C. Lee, A. Scarborough, E. E. Abali, T. Budak-Alpdogan, N. Johnson-Farley,
D. Banerjee, K. W. Scotto, J. R. Bertino, Antitumor and modeling studies of a
penetratin-peptide that targets E2F-1 in small cell lung cancer, Cancer Biol
Ther, 14, 742-751 (2013) PMID: 23792570. PMCID: PMC3841214.
27.
V. Shah, O. Taratula,
O. B. Garbuzenko, M. L. Patil, R. Savla, M. Zhang, T. Minko, Genotoxicity of nanocarriers with different composition,
architecture, size, molecular weight and charge, Current Drug Discovery
Technologies, 10(1), 8-15 (2013) PMID: 22564170, PMCID: PMC3899095.
28.
V. Ivanova, O. B.
Garbuzenko, K. R. Reuhl, D. C. Reimer, V. P. Pozharov, T. Minko, Inhalation Inhalation treatment of pulmonary fibrosis by
liposomal prostaglandin E2, Eur J Pharm Biopharm, 84, 335-344 (2013) PMID:
23228437, PMCID: PMC3660419.
29.
M. Zhang, O. B.
Garbuzenko, K. R. Reuhl, L. Rodriguez-Rodriguez, T. Minko, Two-in-one: combined targeted
chemo and gene therapy for tumor suppression and prevention of metastases,
Nanomedicine (Lond), 7(2), 185-197 (2012) PMID: 22339132.
30.
L. Sheihet, O. B.
Garbuzenko, J. Bushman, M. K. Gounder, T.
Minko, J. Kohn, Paclitaxel in tyrosine-derived nanospheres as a potential
anti-cancer agent: In vivo evaluation of toxicity and efficacy in comparison
with paclitaxel in Cremophor. Eur J Pharm Sci. 45(3), 320-329 (2012) PMID:
22155544.
31.
O. Taratula, O. B.
Garbuzenko, A. M. Chen, T. Minko,
Innovative strategy for treatment of lung cancer: targeted nanotechnology-based
inhalation co-delivery of anticancer drugs and siRNA, J. Drug Target., 19(10),
900-914 (2011) PMID: 21981718.
32.
M. Nadler-Milbauer, L.
Apter, Y. Haupt, S. Haupt, Y. Barenholz, T.
Minko, A. Rubinstein, Synchronized release of Doxil and Nutlin-3 by remote
degradation of polysaccharide matrices and its possible use in the local treatment
of colorectal cancer, J. Drug Target., 19(10), 859-873 (2011) PMID: 22082104.
33.
S. Betigeri, M. Zhang,
O. Garbuzenko, T. Minko, Non-viral
delivery of siRNA or antisense oligonucleotides targeted to Jun N-Terminal
Kinase 1 prevents cellular hypoxic damage, Drug Deliv. and
Transl. Res., 1, 13–24 (2011) PMID: 21461383, PMCID: PMC3063508.
34.
Savla R., Taratula O.,
Garbuzenko O., Minko T., Tumor
targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and
treatment of cancer, J Control Release, 153(1), 16-22 (2011) PMID: 21342659.
35.
M. L. Patil, M. Zhang,
O. B. Garbuzenko, T. Minko,
Multifunctional triblock nanocarrier (PAMAM-PEG-PLL) for the efficient
intracellular delivery of siRNA and potent gene silencing, ACS Nano, 5(3),
1877-1887 (2011) PMID: 21322531, PMCID: PMC3062392.
36.
O. Taratula, R. Savla,
H. He, T. Minko, Poly(propyleneimine)
dendrimers as potential siRNA delivery nanocarrier: from structure to function,
Int. J. Nanotechnology, 8, 36 – 52 (2011).
37.
O. Taratula, R. Savla,
Y. A. Wang, H. He, T. Minko,
Multifunctional nanomedicine platform for cancer specific delivery of siRNA by
supermagnetic iron oxide nanoparticles/dendrimer complexes, Curr. Drug
Delivery, 8(1), 59-69 (2011) PMID: 21034421.
38.
N. Dayan, V. Shah, T. Minko, Preliminary evaluation of the
genotoxic potential of a hydrophilic polymer with three preservation systems,
Int J Cosmet Sci, 33, 497-502 (2011) PMID: 21696404.
39.
N. Dayan, V. Shah, T. Minko, Genotoxic potential evaluation
of a cosmetic insoluble substance by the micronuclei assay, J. Cosmet. Sci., 62,
29-39 (2011) PMID 21443843.
40.
N. Dayan, V. Shah, T. Minko, Correlation between cell
viability and DNA damage: Studying chromosomal effect of cosmetic substances,
J. Cosmetic Sci., 62, 70-71 (2011).
41.
P. Chandna, J. J.
Khandare, E. Ber, L. Rodriguez-Rodriguez, T.
Minko, Targeted multicomponent polymer-peptide-drug conjugates for
treatment of primary and metastatic cancers, Pharm. Res., 27, 2296-2306 (2010).
42.
O. B. Garbuzenko, M.
Saad, V. P. Pozharov, K. R. Reuhl, G. Mainelis, T. Minko. Inhibition of lung tumor growth by complex pulmonary
delivery of drugs with oligonucleotides as suppressors of cellular resistance,
Proc. Natl. Acad. Sci. USA, 107, 10737-10742 (2010).
43.
A. M. Chen, O.
Taratula, D. Wei, H.-I. Yen, T. Thomas, T. J. Thomas, T. Minko, H. He, Labile Catalytic Packaging of DNA siRNA: Control
of Gold Nanoparticles out of DNA siRNA Complexes, ACS Nano, 4, 3679-3688
(2010).
44.
T. Minko, M. L. Patil,
M. Zhang, J. J. Khandare, M. Saad, P. Chandna, O. Taratula, LHRH-targeted
nanoparticles for cancer therapeutics, Methods Mol Biol., 624, 281-294 (2010).
45.
T. Minko, HPMA
copolymers for modulating cellular signaling and overcoming multidrug
resistance, Adv. Drug Deliver. Rev., 62, 192-202 (2010).
46.
D. A. Christian, O. B.
Garbuzenko, T. Minko, D. E. Discher,
Polymer Vesicles with a Red Cell-like Surface Charge: Microvascular imaging and
in vivo Tracking with Near-Infrared Fluorescence, Macromol. Rapid Commun., 31, 135-141 (2010).
47.
A. M. Chen, M. Zhang,
D. Wei, D. Stueber, O. Taratula, T.
Minko, H. He, Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous
Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug
Resistant Cancer Cells, Small, 5, 2673-2677 (2009).
48.
O. Taratula, O. B.
Garbuzenko, P. Kirkpatrick, I. Pandya, R. Savla, V. P. Pozharov, H. He, T. Minko, Surface-engineered targeted PPI
dendrimer for efficient intracellular and intratumoral siRNA delivery, J.
Control. Release, 140, 284-293 (2009).
49.
M. L. Patil, M. Zhang,
O. Taratula, O. B. Garbuzenko, H. He, T.
Minko, Internally Cationic Polyamidoamine PAMAM-OH Dendrimers for siRNA
Delivery: Effect of the Degree of Quaternization and Cancer Targeting,
Biomacromolecules, 10, 258-266 (2009).
50.
O. B. Garbuzenko, M.
Saad, S. Betigeri, M. Zhang, A. A. Vetcher, V. A. Soldatenkov, D. C. Reimer, T. Minko, Intratracheal versus
intravenous liposomal delivery of siRNA, antisense oligonucleotides and
anticancer drug, Pharm. Research, 26, 382-394 (2009).
51.
D. Christian, S. Cai,
O. Garbuzenko, T. Harada, A. Zajac, T.
Minko, D. Discher, Flexible Filaments for in vivo Imaging and Delivery:
Persistent Circulation of Filomicelles Opens the Dosage Window for Sustained
Tumor Shrinkage, Mol. Pharm., 6, 1343-1352 (2009).
52.
Z. Keresztessy, M.
Bodnar, E. Ber, I. Hajdu, M. Zhang, J. F. Hartmann, T. Minko, J. Borbely, Self-Assembling Chitosan/Poly-γ-Glutamic
Acid Nanoparticles for Targeted Drug Delivery, Colloid and Polymer Science,
287, 759–765 (2009).
53.
M. Saad, O. B.
Garbuzenko, T. Minko, Co-delivery of
siRNA and an anticancer drug for treatment of multidrug resistant cancer,
Nanomedicine (Lond), 3, 761-776 (2008).
54.
M. Saad, O. B.
Garbuzenko, E. Ber, P. Chandna, J. J. Khandare, V. P. Pozharov, T. Minko, Receptor targeted polymers,
dendrimers, liposomes: Which nanocarrier is the most efficient for
tumor-specific treatment and imaging? J. Control. Release, 130, 107-114 (2008).
55.
M. L. Patil, M. Zhang,
S. Betigeri, O. Taratula, H. He, T.
Minko, Surface Modified and Internally Cationic Polyamidoamine Dendrimers
for Efficient siRNA Delivery, Bioconjugate Chem., 19, 1396-403 (2008).
56.
Y. Wang, M. Saad, R.
I. Pakunlu, J. J. Khandare, O. B. Garbuzenko, A. A. Vetcher, V. A. Soldatenkov,
V. P. Pozharov, T. Minko, Non-viral
nanoscale-based delivery of antisense oligonucleotides targeted to HIF1 alpha
enhances the efficacy of chemotherapy in drug resistant tumor, Clin. Cancer
Res., 14, 3607-3616 (2008).
57.
S. Jayant, J. J.
Khandare, Y. Wang, A. P. Singh, N. Vorsa, T.
Minko, Targeted sialic acid - doxorubicin prodrugs for intracellular
delivery and cancer treatment, Pharm. Res., 24, 2120-2130 (2007).
58.
T. Minko,
Intracellular delivery, Pharm. Res., 24, 2097-2098 (2007).
59.
P. Chandna, M. Saad,
E. Ber, J. J. Khandare, A. A. Vetcher, V. A. Soldatenkov, T. Minko, Targeted proapoptotic anticancer drug delivery system,
Mol. Pharm., 4,668-678 (2007).
60.
S. Zalipsky, M. Saad,
R. Kiwan, E. Ber, N. Yu, T. Minko,
Antitumor activity of new liposomal prodrug of Mitomycin C in multidrug
resistant solid tumor: Insights of the mechanism of action, J. Drug Target.,
15, 518-530 (2007).
61.
Y. Geng, P. Dalhaimer,
S. Cai, R. Tsai, M. Tewari, T. Minko,
D. E. Discher, Shape effects of filaments versus spherical particles in flow
and drug delivery, Nature Nanotech., 2, 249 – 255 (2007).
62.
J. J. Khandare, T. Minko, Antibodies and peptides in
cancer therapy, Crit. Rev. Ther. Drug Carrier Syst., 23, 401-435 (2006).
63.
J. J. Khandare, S.
Jayant, A. Singh, P. Chandna, Y. Wang, N. Vorsa, T. Minko, Dendrimer versus linear
conjugate: influence of polymeric architecture on the delivery and anticancer
effect of paclitaxel, Bioconjugate Chem., 17, 1464-1472 (2006).
64.
T. Minko, R. I.
Pakunlu, Y. Wang, J. J. Khandare, M. Saad, New generation of liposomal drugs
for cancer, Anticancer Agents Med. Chem., 6, 537-552 (2006).
65.
F. Ahmed, R. I.
Pakunlu, A. Brannan, F. Bates, T. Minko,
D. E. Discher, Biodegradable polymersomes loaded with both paclitaxel and
doxorubicin permeate and shrink tumors by inducing apoptosis in proportion to
accumulated drug, J. Controlled Rel.,
116, 150-158 (2006).
66.
R. I Pakunlu, Y. Wang,
M. Saad, J. J. Khandare, V. Starovoytov, T.
Minko, In vitro and in vivo intracellular liposomal delivery of antisense
oligonucleotides and anticancer drug, J. Controlled Rel., 114, 153-162 (2006).
67.
S. Betigeri, R.I.
Pakunlu, Y. Wang, J.J. Khandare, T.
Minko, JNK1 as a molecular target to limit cellular mortality under
hypoxia, Mol. Pharm., 3, 424-430 (2006).
68.
J. J. Khandare, P.
Chandna, Y. Wang, V. P. Pozharov, T.
Minko, Novel polymeric prodrug with
multivalent components for cancer therapy, J. Pharmacol. Exp. Ther., 317,
929-937 (2006).
69.
J. J. Khandare, T. Minko, Polymer-drug conjugates:
Progress in polymeric prodrugs, Prog. Polym. Sci., 31, 359-397 (2006).
70.
S. S. Dharap, P.
Chandna, Y. Wang, J. J. Khandare, B. Qiu, S. Stein, T. Minko, Molecular targeting of BCL2 and BCLXL proteins by
synthetic BH3 peptide enhances the efficacy of chemotherapy, J. Pharmacol. Exp.
Ther. 316, 992-998 (2006).
71.
O. Appenzeller, T. Minko, C. Qualls, V. Pozharov, J.
Gamboa, A. Gamboa, R. F. Pakunlu, Chronic hypoxia in Andeans; are there lessons
for neurology at sea level? J Neurol Sci., 247, 93-99 (2006).
72.
F. Ahmed, R. I.
Pakunlu, G. Srinivas, A. Brannan, F. Bates, M. L. Klein, T. Minko, D. E. Discher, Shrinkage of a rapidly growing tumor by
drug-loaded polymersomes: pH-triggered release through copolymer degradation, Mol.
Pharm, 3, 340-350 (2006).
73.
O. Appenzeller, T. Minko, C. Qualls, V. Pozharov, J.
Gamboa, A. Gamboa, Y. Wang, Gene expression, hypoxia and aging in the high
Andis; lessons for medicine at sea level?, High Alt. Med. Biol., 16, 217-22
(2006).
74.
O. Appenzeller, T. Minko, C. Qualls, V. Pozharov, J.
Gamboa, A. Gamboa, Y. Wang. Gene expression, autonomic function and chronic
hypoxia: Lessons from the Andis, Clin Auton Res., 16, 217-222 (2006).
75.
S. S. Dharap, Y. Wang,
P. Chandna, J. J. Khandare, B. Qiu, S. Gunaseelan, P. J. Sinko, S. Stein, A. V.
Farmanfarmanian, T. Minko,
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide,
Proc. Natl. Acad. Sci. USA, 102, 12962-12967 (2005).
76.
D. Yu, P. Peng, S. S.
Dharap, Y. Wang, M. Mehlig, P. Chandna, H. Zhao, D. Filpula, K. Yang, V.
Borowski, G. Borchard, Z. Zhang, T.
Minko, Antitumor activity of poly(ethylene glycol) – camptothecin
conjugate: the inhibition of tumor growth in vivo, J. Controlled Rel., 110,
90-102 (2005).
77.
O. Appenzeller, T. Minko, C. Qualls, V. Pozharov, J.
Gamboa, A. Gamboa, Y. Wang, Migraine in the Andes and headache at sea level,
Cephalalgia, 25, 1117-1121 (2005).
78.
T. Minko, Soluble
polymer conjugates for drug delivery, Drug Discovery Today, 2, 15-20 (2005).
79.
T. Minko, Y. Wang, V.
Pozharov, Remediation of cellular hypoxic damage by pharmacological agents, Curr.
Pharm. Des., 11, 3185-3199 (2005).
80.
T. Minko, E. V.
Batrakova, S. Li, Y. Li, R. I. Pakunlu, V. Yu. Alakhov, A. V. Kabanov, Pluronic
Block Copolymer Formulation with Doxorubicin Induces Apoptosis in
Drug-Resistant Cancer Cells, J. Controlled Rel., 105, 269-278 (2005).
81.
Y. Wang, T. Minko, A novel cancer therapy:
Liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides in
combination with hypoxia and doxorubicin, Biochem. Pharmacol.,
68, 2031-2042 (2004).
82.
R. I. Pakunlu, Y.
Wang, W. Tsao, V. Pozharov, T. J. Cook, T.
Minko, Enhancement of the efficacy of chemotherapy for lung cancer by
simultaneous suppression of multidrug resistance and antiapoptotic cellular
defense: novel multicomponent delivery system, Cancer Res., 64, 6214-6224
(2004).
83.
T. Minko, S. S.
Dharap, R. I. Pakunlu, Y. Wang, Molecular targeting of drug delivery systems to
cancer, Curr. Drug Targets, 5, 389-406 (2004).
84.
Y. Wang, R. I.
Pakunlu, W. Tsao, V. Pozharov, T. Minko,
Bimodal effect of hypoxia in cancer: the role of hypoxia inducible factor in
apoptosis, Mol. Pharm., 1, 156-165 (2004).
85.
T. Minko, Drug
targeting to the colon with lectins and neoglycoconjugates, Adv. Drug Deliver.
Rev., 56, 491-509 (2004).
86.
S. Jin, A. S. Mathis,
K. Gioia, T. Minko, G. S. Friedman,
J. A. Rosenblatt, F. Peng, G. T. Knipp, The effect of tacrolimus on the
expression of macrophage scavenger and nuclear hormone receptors in THP-1
derived human macrophages, Transplantation, 77, 1281-1287 (2004).
87.
S. Jin, A. S. Mathis,
J, Rosenblatt, T. Minko, G. S.
Friedman, K. Goia, G. T. Knipp, Insights into cyclosporine A-induced
atherosclerotic risk in transplant recipients: Macrophage scavenger receptor
regulation, Transplantation, 77, 497-504 (2004).
88.
David, P. Kopeckova, T. Minko, A, Rubinstein, J. Kopecek,
The involvement of endogenous lectins in mediating the antitumor activity of
targetable HPMA copolymer-doxorubicin conjugates in human colon adenocarcinoma
and hepatocarcinoma cells, Eur. J. Cancer, 40, 148-157 (2004).
89.
S. S. Dharap, B. Qiu,
G. Williams, P. J. Sinko, S. Stein, T.
Minko, Molecular targeting of drug delivery systems to ovarian cancer by
BH3 and LHRH peptides, J. Controlled Rel., 91, 61-73 (2003).
90.
T. Minko, S. S. Dharap, A. T. Fabbricatore,
Enhancing the efficacy of chemotherapeutic drugs by the suppression of
antiapoptotic cellular defense, Cancer Detect. Prev., 27, 193-202 (2003).
91.
S. S. Dharap, T.
Minko, Targeted proapoptotic LHRH-BH3 peptide, Pharm. Res., 20, 889-896
(2003).
92.
R. I. Pakunlu, T. J. Cook, T. Minko, Simultaneous modulation of multidrug resistance and
antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense
oligonucleotides enhances the anticancer efficacy of doxorubicin, Pharm. Res.,
20, 351-359 (2003).
93.
W. K. Nichols, R. Mehta, K. Skordos, K. Mace, A. M.A.
Pfeifer, B. A. Carr, T. Minko, S. W.
Burchiel, G. S. Yost, 3-Methylindole-Induced Toxicity to Human Bronchial
Epithelial Cell Lines, Toxicol. Sci., 71, 229-236 (2003).
94.
O. Appenzeller, T.
Minko, V. Pozharov, M. Bonfichi, L. Malcovati, J. Gamboa, L. Bernardi, Gene
expression in the Andes and neurology at sea level, J. Neurol. Sci., 207, 37-41
(2003).
95.
C. M. Peterson, J.-G. Shiah, Y. Sun, P. Kopeckova, T. Minko, R. C. Straight, J. Kopecek,
HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian
cancer, Adv. Exp. Med. Biol., 519, 101-123 (2003).
96.
T. Minko, A.
Stefanov, V. Pozharov, Lung hypoxia: Antioxidant and
antiapoptotic effects of liposomal alpha tocopherol, J. Appl. Physiol., 93,
1550-1560 (2002).
97.
T. Minko,
P. Paranjpe, B. Qiu, A. Lalloo, R. Won,
S. Stein, P. J. Sinko, Enhancing the anticancer efficacy of camptothecin using
biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug
resistant human ovarian carcinoma cells, Cancer Chemoth. Pharm., 50, 143-150
(2002).
98.
T. Minko,
Enhancing the efficacy of anticancer drugs using complex multicomponent
advanced drug delivery systems, Business Briefing: Future Drug Discovery, 12,
134-136 (2001).
99.
T. Minko, S.
S. Dharap, R. I. Pakunlu, J. L. Colaizzi, Advanced drug delivery systems in
cancer chemotherapy, Disease Management Clin. Outcomes, 3, 48-54 (2001).
100.
T. Minko, P.
Kopeckova, J. Kopecek, Preliminary evaluation of caspase-dependent apoptosis
signaling pathways of free and HPMA copolymer-bound doxorubicin in human
ovarian carcinoma cells, J. Controlled Rel., 71, 227-237 (2001).
101.
J. Kopecek, P. Kopeckova, T. Minko, Z-R. Lu,
C. M. Peterson, Water soluble polymers in tumor targeted delivery, J.
Controlled Rel., 74, 147-158
(2001).
102.
Y. Kasuya, Z-R. Lu, P. Kopeckova, T. Minko, S. E. Tabibi, J. Kopecek, Synthesis and characterization
of HPMA copolymer aminopropylgeldanamycin conjugates, J. Controlled
Rel., 74, 203-211 (2001).
103.
T. Minko, P.
Kopeckova, J. Kopecek, Antitumor activity and apoptosis signaling pathways of
HPMA copolymer-bound doxorubicin, J. Controlled Rel., 74, 370-370
(2001).
104.
T. Minko, P.
Kopeckova, J. Kopecek, Efficacy
of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid
tumor model of ovarian carcinoma, Int. J. Cancer, 86, 108-117 (2000).
105.
T. Minko, P.
Kopeckova, V. Pozharov, K. Jensen, J. Kopecek, The influence of cytotoxicity of
macromolecules and of VEGF gene modulated vascular permeability on the enhanced
permeability and retention effect in experimental resistant solid tumor, Pharm.
Res. 17, 505-514 (2000).
106.
M. Demoy, T.
Minko, P. Kopeckova, J. Kopecek, Time- and concentration-dependent
apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in
human ovarian carcinoma cells, J. Controlled Rel., 69, 185-196 (2000).
107.
J. Kopecek, P.
Kopeckova, T. Minko, Z-R. Lu, HPMA
copolymer-anticancer drug conjugates: Design, activity, and mechanism of
action, Eur. J. Pharm. Biopharm, 50, 61-81 (2000).
108.
K. Kunath, P. Kopeckova, T. Minko, J. Kopecek, HPMA copolymer-anticancer drug-OV-TL16
Antibody conjugates. 3. The effect of free and polymer-bound adriamycin
on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell
line, Eur. J. Pharm. Biopharm, 49, 11-15 (2000).
109.
D. Wang, P. Kopeckova, T. Minko, V. Nanayakkara, J. Kopecek, Synthesis of starlike
N-(2-Hydroxypropyl)methacrylamide copolymers: Potential drug curriers,
Biomacromolecules, 1, 313-319 (2000).
110.
T. Minko, P.
Kopeckova, J. Kopecek, Comparison of the anticancer effect of free and HPMA
copolymer-bound adriamycin in human ovarian carcinoma cells, Pharm. Res., 16,
986-996 (1999).
111.
T. Minko, P.
Kopeckova, J. Kopecek, Chronic exposure to HPMA copolymer bound adriamycin does
not induce multidrug resistance in a human ovarian carcinoma cell line, J. Controlled
Rel., 59, 133-148 (1999).
112.
W.-M. Choi, P. Kopeckova, T. Minko, J. Kopecek, Synthesis of HPMA copolymer containing
adriamycin bound via an acid-labile spacer and its activity toward human
ovarian carcinoma cells, J. Bioact. Comp. Polym., 14, 447-556 (1999).
113.
T. Minko,
P. Kopeckova, V. Pozharov, J. Kopecek, HPMA copolymer bound adriamycin
overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line,
J. Controlled Rel. 54, 223-233 (1998).
114.
F. Meerson, V.
Pozharov, T. Minyailenko (Minko),
Superresistance against hypoxia after preliminary adaptation to repeated
stress, J. Appl. Physiol. 76, 1856-1861 (1994).
115.
V. Pozharov, T.
Minyailenko (Minko), Lipid peroxidation during severe hypoxia: possible
mechanisms of the activation, Hypoxia Medical J. N3, 14-17
(1993).
116.
F. Z. Meerson, V. P. Pozharov, T. D. Miniailenko (Minko), L. Yu Golubeva, Adaptation to stress can
enhance animal resistance to sublethal hypoxia to a greater extent than
adaptation to hypoxia, Bull. Experim. Biol. Med. 116, 574-577 (1993).
117.
F. Z. Meerson, T.D. Miniailenko (Minko), V. P. Pozharov,
Development of super-resistance to hypoxic hypoxia during adaptation to
short-term stress, Bull. Experim. Biol. Med.
115, 132-135 (1993).
118.
F. Z. Meerson, V. P. Pozharov, T.D. Miniailenko (Minko), E. Ya. Vorontsova, S.A.
Radzievsky, Correlation between the antihypoxic effect of adaptation to stress
and the course of electrostimulation, Bull. Experim. Biol. Med. 115, 339-342
(1993).
119.
F. Z. Meerson, T.D. Miniailenko (Minko), V. P. Pozharov, Super-resistance
to hypoxic hypoxia in adaptation to stress exposure: its possible mechanisms,
Aviakosm. Ecol. Med. 27, 44-48 (1993).
120.
F. Z. Meerson, V. P. Pozharov, T. D. Minyailenko
(Minko), Animal
resistance to sublethal hypoxia may be raised more by adaptation to stress than
by adaptation to hypoxia, Bull. Experim. Biol. Med. 116, 1467-1471 (1993).
121.
F. Z. Meerson, V. P. Pozharov, T. D. Minyailenko
(Minko), Antihypoxic effect of
adaptation to stress and of adaptation to electrostimulation – a comparative
study, Bull. Experim. Biol. Med. 115, 349-354 (1993).
122.
F. Z. Meerson, T. D. Minyailenko (Minko), V. P. Pozharov, Development of
superresistance to hypoxia under the effect of adaptation to short-term stress
exposure, Bull. Experim. Biol. Med. 115, 123-126 (1993).
123.
N. G. Sidoryak, T.
Miniailenko (Minko), Influence of prolonged injection of sodium nitrite on
oxygen transport function and acid-base status of blood, Pharmacol. Toxicol., 54, p. 88-92 (1991).
124.
T. Minyailenko (Minko),
V. Pozharov, M. Seredenko, Oxygen supply-consumption ratio as the criterion of
tissue hypoxia, Wiss. Zeitschrift der Humboldt-Univ. zu Berlin, R. Medizin. 40,
97-102 (1991).
125.
M. M. Seredenko, T. D.
Miniailenko (Minko), E. B.
Velikanov, A. V. Koryakin, A. A. Rezayev, Influence of breathing mixture of air
with industrial natural gas contained hydrogen sulfide on glycolysis and lipid
peroxidation in rats, Physiol. J. 37, 71-74 (1991).
126.
T. Minyailenko (Minko),
V. Pozharov, M. Seredenko, Severe hypoxia
activates lipid peroxidation in the rat brain, Chem. Phys. Lipids 55, 25-28
(1990).
127.
V. Pozharov, T.
Miniailenko (Minko), A. Stefanov, S.
Bryginsky, M. Seredenko, V. Lishko, Physiological mechanisms of antihypoxic
effect of liposomes, Sechenov Physiol. J. USSR 76, 897-902 (1990).
128.
Stefanov, V. Pozharov,
T. Miniailenko (Minko), S.
Bryginsky, M. Seredenko, V. Lishko, The Biological effect of liposomes in
hypoxic states of different etiologies, Vestnik Acad. Med. Sci. USSR N6, 47-51
(1990).
129.
V. P. Pozharov, T. D. Miniailenko (Minko), M.M. Seredenko, A.V. Stefanov, E. V. Kasyanova, V. K.
Lishko, F. Z. Meerson, Stress lung syndrome and its correction by phospholipids, Dokl. Acad. Sci. USSR 310,
754-757 (1990).
130.
F. Z. Meerson, T. D. Miniailenko (Minko), V. P. Pozharov, M.M. Seredenko, Disorders of external respiration
and oxygen transport and utilization in stress, Pathol. Physiol. Experim. Therapy 6, 20-26 (1989).
131.
V. R. Tyutyunnik, V. P. Pozharov, T. D. Miniailenko (Minko), M. I. Kalinsky, V. K. Lishko,
M. M. Seredenko, A. V. Stefanov, Usage of liposomal adrenalin for correction of
hypoxia under an exercise, Theory and Practice of Physical Culture N2, 42-45
(1989).
132.
M. M. Seredenko, V. P. Pozharov, T. D. Miniailenko (Minko), V. I. Boyko, L. A. Grabovsky,
External respiration, gas exchange and blood acid-base balance in dogs with
hyperthermia, Physiol. J. 35, 21-25 (1989).
133.
N. G. Sidoryak, T. D. Miniailenko (Minko), Changes in the blood acid-base status in rats under acute
hemic hypoxia, Hemathol. Transfusiol., 11, 64-68
(1988).
134.
M. M. Seredenko, A. A. Moybenko, T. D. Miniailenko (Minko), V. P. Pozharov, L.A.
Grabovsky, E.G. Bidkov, The development of the hypoxic state and the lung blood
oxygenation during hyperthermia, Sechenov Physiol. J. USSR 74, 987-994 (1988).
135.
S. A. Bryginsky, A. V. Zubarenko, V. K. Lishko, T. D.
Miniailenko (Minko), V. P. Pozharov,
E. V. Rozova, M. M. Seredenko, A. V. Stefanov, Using of liposomes for
correction of respiratory hypoxia under experimental pneumonia, Bull. Experim.
Biol. Med. 106, 421-423 (1988).
136.
M. M. Seredenko, B. Ya. Reznik, A. V. Zubarenko, T. D.
Miniailenko (Minko), V. P. Pozharov, E. V. Rozova, A. P. Khirsa,
Peculiarities of the hypoxic state development in children with bronchial
asthma, Physiol. J. 33, 62-66 (1987).
137.
M. M. Seredenko, T. D. Miniailenko (Minko), V. P. Pozharov, Peculiarities of the development and
compensation of secondary tissue hypoxia during exercise, Human Physiol. 13,
831-838 (1987).
138.
S. A. Bryginskiy, A. V. Zubarenko, V. K. Lishko, T. D.
Miniailenko (Minko), V. P. Pozharov,
B. Ya. Reznik, E. V. Rozova, M. M. Seredenko, A. V. Stefanov, Characteristics
of the hypoxic state after administration of liposomes, Dokl. Acad. Sci. USSR
291, 1022-1024 (1986).
139.
M. M. Seredenko, V. P. Pozharov, T. D. Miniailenko (Minko), R. F. Bespal’chaya, Features
of blood oxygenation in the lungs in acute graded blood loss, Physiol. J. 32,
344-350 (1986).
140.
I. Lanovenko, T. D. Miniailenko (Minko), M. M. Seredenko,
System mechanisms of the development and compensation of acute hemic hypoxia
under experimental methemoglobinemia, Pathol. Phisiol. Experim. Therapy 3 LHRH-Targeted
Nanoparticles for Cancer, 50-53 (1986).
141.
M. M. Filippov, T. D. Miniailenko (Minko), Mass transfer of CO2 and acid-base balance
under exercise at sea level and mountain, Ukrainian Biochem. J. 52, 171-174
(1980).
1.
J. Khandare, S. Banerjee, T. Minko, Nanopreparations for Cancer Treatment and Diagnostics,
In: Frontiers in Nanobiomedical Research, Volume 3, Handbook of Nanobiomedical
Research, V. P. Torchilin, Ed., World Scientific, 2014, pp. 2352.
2.
T. Minko, Receptor
Mediated Delivery Systems for Cancer Therapeutic, In: Advances in Delivery
Science and Technology, R. A. Siegel, S. Juergen, M. Rathbone Eds., CRS Press, Springer,
2012, Part 4, pp. 329-355.
3.
S. Cai, D. A. Christian, M.
Tewari, T. Minko, D. E. Discher.
Anti-Cancer Polymerosomes (Chapter 9), In: Polymer-based Nanostructures:
Medical Applications (RSC Nanoscience & Nanotechnology), P. Broz, Ed., RSC Publishing, 2010,
pp. 300-314.
4.
T. Minko, J.
J. Khandare, A. A. Vetcher, V. A. Soldatenkov, O. B. Garbuzenko, M. Saad, V. P.
Pozharov, Multifunctional nanotherapeutics for cancer (Chapter 10), In:
Multifunctional Pharmaceutical Nanocarriers, V. P. Torchilin, Ed., Springer,
2008, pp. 309-335.
5. T. Minko, J. J. Khandare, S. Jayant,
Polymeric Drugs (Chapter 14), In.: Macromolecular Engineering: From Precise
Macromolecular Synthesis to Macroscopic Material Properties and Application,
Volume 4, K. Matyjaszewski, Y. Gnanou, L. Leibler, Eds., WILEY-VCH Verlag GmbH
& Co., 2007, pp. 2541-2595.
6. T. Minko, Hypoxia-induced lung damage
and alpha tocopherol, In.: The Encyclopedia of Vitamin E, V. R. Preedy and R.
Watson, Eds, CAB International, 2006, pp.
699-708.
7. T. Minko, Chapter 22, Drug delivery
systems, In: Martin’s Physical Pharmacy and Pharmaceutical Sciences 5th
Edition, P. J. Sinko, Ed., Lippincott Williams and Wilkins, 2006, pp. 629-680.
8. T. Minko, Chapter 17, Colloids, In:
Martin’s Physical Pharmacy and Pharmaceutical Sciences 5th Editionn,
P. J. Sinko, Ed., Lippincott Williams and Wilkins, 2006, pp. 469-498.
9. T. Minko, Chapter 16, Interfacial
Phenomena, In: Martin’s Physical Pharmacy and Pharmaceutical Sciences 5th
Editionn, P. J. Sinko, Ed., Lippincott Williams and Wilkins, 2006, pp. 437-467.
10. T. Minko. Mechanisms of cellular drug
resistance and strategies to overcome it, In: Biomaterials for Delivery and
Targeting of Proteins and Nucleic Acids, R. I. Mahato, Ed, CRC Press, Boca
Raton, London, New York, Washington, D.C., 2005, pp. 461-492.
11. T. Minko, P. Kopeckova, J. Kopecek,
Mechanism of anticancer action of HPMA copolymer-bound doxorubicin, In:
Polymers in Medicine, Kahovec J., Ed., Wiley-VCH, 2001, pp. 35-47.
12. F. Meerson,
T. Minko, V. Pozharov, E.
Vorontsova, E. Ustinova, Effect of combined adaptation to stress and
intermittent hypoxia on the development of experimental myocardial infarction,
in: Adaptation Biology and Medicine, Vol. 1, B. K. Sharma, N. Takeda, N.K.
Ganguly, P.K. Singal, Eds., Narosa Publishing House, 1997, pp. 419-426.
13. T. D.
Miniailenko (Minko), Mechanisms of
blood acid-base status regulation, in: Development and Compensation Mechanisms
of Hemic Hypoxia, M. M. Seredenko, Ed., Naukova Dumka, 1987, pp. 103-118.
14. M. M.
Seredenko, T. D. Miniailenko (Minko),
V. P. Pozharov, Hemic hypoxia after the blood loss:
Development of hypoxia, in: Development and Compensation Mechanisms of Hemic
Hypoxia, M. M. Seredenko, Ed., Naukova Dumka, 1987, pp. 82-97.
15. M. M.
Seredenko, T. D. Miniailenko (Minko),
V. P. Pozharov, E. V. Rozova, N. G. Sidoryak, Hemic hypoxia in
methemoglobinemia: Development and compensation of hypoxia, in: Development and
Compensation Mechanisms of Hemic Hypoxia, M. M. Seredenko, Ed., Naukova Dumka,
1987, pp. 5-18.
16. M. M.
Seredenko, T. D. Miniailenko (Minko),
V. P. Pozharov, V. P. Rozova, N. G. Sidor’ak, Peculiarities of the hypoxia
development during methemoglobinemia at sea level and in mountains, in:
Adaptation and Resistance of an Organism in Mountains, P. V. Beloshitskiy, Ed.,
Naukova Dumka, 1986, pp. 84-96.
17. P. V.
Beloshitskiy, A. Z. Kolchinskaya, A. P. Andreeva, A. N. Krasyuk, N. V.
Makarenko, L. N Voronina, A. A. Zamchiy, V. M. Kienko, T. A. Kerdeeva, T. D.
Miniailenko (Minko), P. A.
Radzievskiy, N. V. Shtuchenko, Treatment of patients with iron-deficient anemia
living in arid zone in high altitudes, in: Adaptation and Resistance of an
Organism in the Mountains, P. V. Beloshitskiy, Ed., Naukova Dumka, 1986, pp.
105-124.
18. T.
D. Minyailenko (Minko), Changes in
acid-base status and blood gases tension under hypoxia of different genesis,
Naukova Dumka, 1984, pp. 1-23.
19. T. D.
Miniailenko (Minko), Changes in
blood acid-base status under hypoxic hypoxia, in: Secondary Tissue Hypoxia, A.
Z. Kolchinskaya, Ed., Naukova Dumka, 1983, pp. 43-52.
1.
T. Minko,
Book review: Apoptosis and Autoimmunity. From Mechanisms to Treatments, J.R.
Kalden and M. Herrmann, Eds. Wiley-VCH. 2003. 381 pp., Pharmaceutical Research,
vol. 20, Dec.: 2041, 2003.
1. T. Minko, A. Kuzmov, J. Sapiezynski, O. Taratula, V. Shah, M.
Zhang, O. B. Garbuzenko, S. R. Pine, L. Rodriguez-Rodriguez, Nanotechnology
Approaches for Personalized Treatment of Cancer, 42nd Annual Meeting
& Exposition of the Controlled Release Society, July 26-29, 2015, Edinburgh,
Scotland.
2. V.
Ivanova, O. B. Garbuzenko, R. Rustamov, G. Mainelis, T. Minko, Local lung co-delivery of siRNA and drug, 41st
Annual Meeting & Exposition of the Controlled Release Society, July 13-16,
2014, Chicago, Illinois, #144.
3.
R. Savla, O. Garbuzenko, L. Rodriguez-Rodriguez, T. Minko, Targeted nanoparticle-based
system for cancer imaging and diagnosis, 41st Annual Meeting &
Exposition of the Controlled Release Society, July 13-16, 2014, Chicago,
Illinois, #640.
4.
M. Shah, V. Shah, T.
Minko, Water soluble formulations of paclitaxel, 41st Annual
Meeting & Exposition of the Controlled Release Society, July 13-16, 2014,
Chicago, Illinois, #661.
5.
A. Kuzmov, O. Taratula, O. B. Garbuzenko, M. Shah, V.
Shah, T. Minko, Lipid nanoparticles
for inhalation co-delivery of anticancer drug and siRNA, 39th Annual Meeting of
the Controlled Release Society, July 15-18, 2012, Quebec City, Canada, #261.
6.
V. Ivanova, O. B. Garbuzenko, K. R. Reuhl, T. Minko, Liposomal form of prostaglandin
E2 for inhalation treatment of pulmonary fibrosis, 39th Annual Meeting of the
Controlled Release Society, July 15-18, 2012, Quebec City, Canada, #372.
7.
O. Taratula, A. Kuzmov, M. Shah, O. Garbuzenko, T. Minko, Nanostructured lipid carriers
as multifunctional nanomedicine platform for pulmonary co-delivery of
anticancer drugs and siRNA, Nanomedicine and Drug Delivery Symposium,
NanoDDS’11, October 15-16, 2011, Salt Lake City, Utah, p. 50-51.
8.
O. Taratula, M. Shah, O. Garbuzenko, T. Minko, Nanostructured lipid carriers
as multifunctional nanomedicine platform for pulmonary co-delivery of
anticancer drugs and siRNA, 38th Annual Meeting of the Controlled Release
Society, July 31 - August 3, 2011, National Harbor, Maryland, #15.
9.
O. Garbuzenko, O. Taratula, T. Minko, The influence of composition, size, and shape of
nanocarriers on their accumulation and retention in lungs after pulmonary or
intravenous delivery, 38th Annual Meeting of the Controlled Release Society, July
31 - August 3, 2011, National Harbor, Maryland.
10. O.
Taratula, O. B. Garbuzenko, P. Kirkpatrick, I. Pandya, R. Savla, V. P.
Pozharov, H. He, T. Minko, Receptor-targeted
surface-engineered PPI dendrimer for efficient intracellular and intratumoral
siRNA delivery, 37th Annual Meeting of the Controlled Release Society, July
10-14, 2010, Portland, Oregon, #202.
11. O.
Garbuzenko, M. Saad, V. P. Pozharov, K. Reuhl, G. Mainalis, T. Minko, Combinatorial inhalatory
co-delivery of drug and antisense oligonucleotides for treatment of lung
cancer, 37th Annual Meeting of the Controlled Release Society, July 10-14,
2010, Portland, Oregon, #110.
12. T. Minko, Mechanisms of cellular drug resistance
and strategies to overcome it, Symposium on Biomedical Polymers for Drug
Delivery, March 26-27, 2010, Salt Lake City, Utah, p. 19.
13. T. Minko, G. Mainelis, O. Garbuzenko,
S. Seshadri, Inhalatory co-delivery of anticancer drugs and antisense oligonucleotides/siRNA
for lung cancer treatment, 36th Annual Meeting of the Controlled Release
Society, July 18-22, 2009, Copenhagen, Denmark, #136.
14. O.
Garbuzenko, M. Saad, S. Betigeri, M. Zhang, A. A. Vetcher, V. A. Soldatenkov,
D. C. Reimer, T. Minko, Distribution
and retention of anticancer drug, antisense oligonucleotides and siRNA after their systemic and local
liposomal delivery, Annual meeting NanoIsrael, March 30-31, 2009, Jerusalem, Israel.
15. T. Minko, O. Garbuzenko, O. Taratula,
M. Zhang, M. Saad, P. Chandna, M. Patil, J. Khandare, H. He, A. Chen, Receptor
Targeted Nanocarriers for Tumor-Specific Treatment and Imaging, 14th
International Symposium on Recent Advances in Drug Delivery Systems, February
15-18, 2009, Salt Lake City, UT, p.49-50.
16. T. Minko, O. Garbuzenko, O. Taratula,
M. Zhang, M. Saad, P. Chandna, M. Patil, J. Khandare, H. He, A. Chen, Multifunctional
Nanotherapeutics for Cancer Treatment, American
Association for Cancer Research – American Chemical Society Joint Conference
on: Chemistry in Cancer Research: A Vital Partnership in Drug Discovery and
Development, February 8-11, 2009, New Orleans, LA.
17. M.
Zhang, M. L. Patil, S. Betigeri, O. Taratula, H. He, T. Minko, Synthesis and evaluation of modified PAMAM dendrimer as
efficient siRNA delivery system, 35th Annual Meeting of the Controlled Release
Society, July 12-16, 2008, New York, NY, #229.
18. O.
Garbuzenko, M. Saad, S. Betigeri, E. Ber, M. Zhang, A. A. Vetcher, V. A.
Soldatenkov, T. Minko, Influence of
size, charge, shape, and route of liposomes administration on their cellular
uptake, tumor and organs distribution in mice with subcutaneous and orthotropic
models of ovarian and lung carcinomas, 35th Annual Meeting of the Controlled
Release Society, July 12-16, 2008, New York, NY, #763.
19. M.
Saad, O. B. Garbuzenko, E. Ber, P. Chandna, J. J. Khandare, V. P. Pozharov, T. Minko, Receptor targeted polymers,
dendrimers, liposomes: Which nanocarrier is the most effective for tumor
specific treatment and imaging?, 35th Annual Meeting of the Controlled Release
Society, July 12-16, 2008, New York, NY, #92.
20. Chandna,
M. Saad, Y. Wang, E. Ber, J. Khandare, A. A. Vetcher, V. A. Soldatenkov, T.
Minko, A novel targeted proapoptotic drug delivery system for efficient
anticancer therapy, 35th Annual Meeting of the Controlled Release Society, July
12-16, 2008, New York, NY, #616.
21. S.
Betigeri, O. B. Garbuzenko, T. Minko,
JNK1 as a molecular target to limit cellular damage under hypoxia, 35th Annual
Meeting of the Controlled Release Society, July 12-16, 2008, New York, NY, #30.
22. O.
Taratula, P. Kirkpatrick, R. Savla, I. Pandya, T. Minko, H. He, Toward in vivo targeting delivery of siRNA for efficient
cancer therapy, 35th Annual Meeting of the Controlled Release Society, July
12-16, 2008, New York, NY, #874.
23. R.
Savla, O. Taratula, I. Pandya, A. Wang, T.
Minko, H. He, Multifunctional siRNA delivery system for cancer therapy,
35th Annual Meeting of the Controlled Release Society, July 12-16, 2008, New
York, NY, #191.
24. M.
Chen, O. Taratula, D. Wei, T. Minko,
H. He, Labile catalytic packaging and delivering of short interference RNA to
cancer cells: Control of gold nanoparticles “out” of siRNA complexes, NSTI
Nanotech 2008 11th Annual Meeting, June 1-5, 2008, Boston, MA, pp.
342-345.
25. O.
Taratula, P. Kirkpatrick, R.Salva, I. Pandya, T. Minko, H. He, Toward in vivo targeting delivery of siRNA for
efficient cancer therapy, NSTI Nanotech 2008 11th Annual Meeting,
June 1-5, 2008, Boston, MA, pp. 346-349.
26. O.
Taratula, R. Salva, I. Pandya, A. Wang, T.
Minko, H. He, Multifunctional siRNA delivery system for cancer therapy,
NSTI Nanotech 2008 11th Annual Meeting, June 1-5, 2008, Boston, MA,
pp. 349-352.
27. T. Minko, P. Chandna, S. S. Dharap, O.
Garbuzenko, J. J. Khandare, R. I. Pakunlu, M. Saad, Y. Wang, Tumor-specific
targeting of drug delivery systems for cancer therapy and imaging, 34th Annual
Meeting of the Controlled Release Society, July 7-11, 2007, Long Beach, CA, #
162.
28. Shenshen,
T. Minko, D. E. Discher,
Poly(ethilene oxide)-poly(ε-caprolactone) micelles in different
morphologies: Advantages of worm-like micelles for delivery of paclitaxel in
lung cancer therapy, 34th Annual Meeting of the Controlled Release Society,
July 7-11, 2007, Long Beach, CA, #7.
29. T. Minko, J. J. Khandare, P. Chandna, S. S. Dharap,
Y. Wang, Targeted polymeric prodrug with multivalent components for
cancer therapy, 7th International Biorelated Polymers Symposium on Drug
Delivery, Biosurfaces, Hydrogels, Nanostructures, Tissue Engineering and Biomaterials,
ACS National Meeting, San Francisco, CA, September 10-15, 2006, Polymer
Preprints, 47, 199-200 (2006).
30. T. Minko, J. J. Khandare, P. Chandna, S.
S. Dharap, Y. Wang, Straight to the Target: A Novel Polymeric Prodrug with
Multivalent Components for Cancer Therapy, 33 International Symposium on
Controlled Release of Bioactive Materials, Vienna, Austria, July 22-26, 2006,
No 58.
31. T. Minko, Y. Wang, J. J. Khandare,
Hypoxia Inducible Factor - Targeted Anticancer Prodrug, 32 International
Symposium on Controlled Release of Bioactive Materials, Miami, FL, June 18-22,
2005, No 72.
32. E.
Batrakova, T. Minko, S. Li, Y. Li,
R. Pakunlu, V. Alakhov, A. Kabanov, Pluronic block copolymer formulation with
doxorubicin induces apoptosis in drug-resistant cancer cells, 32 International
Symposium on Controlled Release of Bioactive Materials, Miami, FL, June 18-22,
2005, No 242.
33. T. Minko, S. S. Dharap, S. Gunaseelan,
P. J. Sinko, S. Stein, B. Qiu, Targeted delivery of anticancer drugs and
peptides by polyethylene glycol conjugates, 7th Symposium on Biomaterials Science,
New Brunswick, NJ, October 21-22, 2004, p. 34-35.
34. T. Minko, S. S. Dharap, S. Gunaseelan,
S. Stein, P. J. Sinko, R. I. Pakunlu, Y. Wang, B. Qiu, Targeted proapoptotic
anticancer drug delivery system, 31 International Symposium on Controlled
Release of Bioactive Materials, Honolulu. HI, June 12-16, 2004, #108.
35. K.
Lalloo, R. J. Paranjpe, T. Minko, P.
J. Sinko, Liposomal camptothecins exhibit enhanced cytotoxicity, 30th
International Symposium on Controlled Release of Bioactive Materials, Glasgow,
Scotland, United Kingdom, July 2003, #183.
36. T. Minko, P. Sinko, S Stein, S. S.
Dharap, B. Qiu, A. T. Fabbricatore, Y. Wang, Molecular targeting of drug
delivery systems to ovarian cancer by BH3 and LHRH peptides, CRS & NCI
International Symposium on Tumor Targeted Delivery Systems, National Cancer
Institute, Rockville, MD, September 23-25, 2002, pp. 6-9.
37. T. Minko, T. J. Cook, R. I. Pakunlu,
Simultaneous modulation of multidrug resistance and antiapoptotic cellular
defense with liposomes containing doxorubicin and antisense oligonucleotides
targeting mdr1 and bcl-2 mRNA, 29th International Symposium on Controlled
Release of Bioactive Materials, Seoul, Korea, July 20-25, 2002, pp. 322-323.
38. Marin,
M. Muniruzzaman, T. Minko, N.
Rapoport, Acoustic activation of micellar drug delivery: effect of pulsed
ultrasound, 10th International Symposium on Recent Advances in Drug
Delivery Systems, Salt Lake City, UT, February 19-22, 2001, pp 186-187.
39. P.
Kopeckova, T. Minko, Z.-R. Lu, J.
Kopecek, Bioconjugates for the Treatment of Cancer, 28th International
Symposium on Controlled Release of Bioactive Materials, San Diego, CA, June
24-27, 2001, pp. 71-72.
40. J.
Kopecek, P. Kopeckova, T. Minko,
Z.-R. Lu, C. M. Peterson, Water soluble polymers in tumor targeted delivery,
Int. Symposium on Tumor Targeted Delivery Systems, National Institute of
Health, Bethesda, MD, September 25-27, 2000, pp. 1-4.
41. T. Minko, P. Kopeckova, J. Kopecek,
Role of caspases in cellular signal transduction pathways of apoptosis induced
by free and HPMA copolymer-bound doxorubicin, The 27th International Symposium
on Controlled Release of Bioactive Materials, Paris, France, 2000, pp.71-72.
42. M. Demoy, T. Minko, P. Kopeckova, J. Kopecek, Apoptosis induction by free and HPMA copolymer-bound doxorubicin in
human ovarian carcinoma cells, The 27th International Symposium on Controlled
Release of Bioactive Materials, Paris, France, 2000, pp. 203-204.
43. Wang,
P. Kopeckova, T. Minko, V.
Nanayakkara, J. Kopecek, Synthesis of star-like poly[N-(2-hydroxypropyl)methacrylamide]
using PAMAM dendrimer as the core, ACS National Meeting, San Francisco, CA,
Polymer Preprints, 41, 994-995, 2000.
44. T. Minko, P. Kopeckova, J. Kopecek, EPR
effect, multidrug resistance and the efficacy of HPMA copolymer-bound
adriamycin in solid tumors with high vascularization, The 26th International
Symposium on Controlled Release of Bioactive Materials, Boston, MA, 1999, pp.
46-47.
45.
J. Kopecek, P. Kopeckova, T. Minko, HPMA copolymer anticancer drugs: Mechanism of action on cellular
and subcellular levels, The 26th International Symposium on Controlled Release
of Bioactive Materials, Boston, MA, 1999, pp. 24-25.
46.
T. Minko,
P. Kopeckova, J. Kopecek, Signaling pathways of multidrug resistance and
apoptosis in human ovarian carcinoma cells exposed to free and HPMA
copolymer-bound adriamycin, 9th International Symposium on Recent
Advances in Drug Delivery Systems, Salt Lake City, UT, 1999, pp. 215-216.
47.
T. Minko,
P. Kopeckova, V. Pozharov, J. Kopecek, Peculiarities of apoptosis induction and
cell metabolism in human ovarian carcinoma cell lines exposed to free and HPMA
copolymer bound adriamycin, The 25th International
Symposium on Controlled Release of Bioactive Materials, Las Vegas, NV, 1998,
pp. 99-100.
48.
T. Minko, V. Pozharov,
A. Stefanov, Use of liposomes for vitamin E delivery: Antihypoxic and
antioxidant effects, 8th International Symposium on Resent Advances in Drug
Delivery Systems, Salt Lake City, UT, 1997, pp. 252-253.
49.
T. Minyailenko (Minko), V. Pozharov, V. Bystrjukov, O.
Ezhova, F. Meerson, Adaptation to moderate stress increases the resistance to
severe hypoxia, in: High-Altitude Medicine, G.Ueda, J.T.Reeves, M.Sekiguchi,
Eds., Shinshu University Press, 1992, pp. 70-74.
50.
T. Serebrovskaya, Z.
Serebrovskaya, G. Afonina, T. Minyailenko (Minko),
Effect of intermittent hypoxic training on human respiration, free radical
process and immune system, in: High-Altitude Medicine, G.Ueda, J.T.Reeves,
M.Sekiguchi, Eds., Shinshu University Press, 1992, pp. 77-82.
51.
V. Pozharov, T.
Minyailenko (Minko), O. Ezhova, V.
Bystrjukov, A. Sidorenko, Changes in the respiratory sensitivity to carbon
dioxide under severe hypoxia, in: High-Altitude Medicine, G.Ueda, J.T.Reeves,
M.Sekiguchi, Eds., Shinshu University Press, 1992 pp. 123-127
52.
V. P. Pozharov, T. D. Minyailenko (Minko), V. A. Bystrjukov, O. A. Ezhova, Mechanisms of an increase in the
fitness to work during training to intermittent high-altitude hypoxia, in:
Interval Hypoxic Training: Efficiency
and Mechanisms of Action, A. Z. Kolchinskaya, Ed., Naukova Dumka, 1992, pp. 136-139.
53.
T.D. Minyailenko (Minko), V. P. Pozharov, The criterion for the selection of hypoxic
impacts for interval hypoxic training, in: Interval Hypoxic Training:
Efficiency and Mechanisms of Action, A. Z. Kolchinskaya, Ed., Naukova Dumka, 1992, pp. 132-135.
54.
T. D. Minyailenko (Minko), Primary and secondary disturbances of acid-base
homeostasis, in: Acid-base and Thermal Homeostasis,
Irzhak L. I., Ed., Syktyvkar University
Press, 1991, pp. 57-61.
55.
M. M. Seredenko, N. G. Sidoryak, T. D.
Minyailenko (Minko), V. A.
Bystrjukov, Acid-base homeostasis under hemic hypoxia, in: Acid-base and
Thermal Homeostasis, Irzhak L. I., Ed., Syktyvkar University Press, 1991, pp.
80-86.
56.
M.M. Seredenko, V.A. Bystrjukov, V.P. Pozharov,
T.D. Miniailenko (Minko), V.R.
Tyutyunnik, Peculiarities of the reaction on exercise trained and untrained
rats with different types of breathing, in: Exercise Hypoxia: Digital Models,
Prognosis and Correction, A. Z. Kolchinskaya, Ed., Naukova Dumka, 1990, pp. 71-73.
57.
V. P. Pozharov, T. D. Minyailenko, Compensative
and adaptive shifts of respiration, gas exchange and blood acid-base status
during hypoxia of different genesis, in: Compensative and Adaptive Reactions of
Organism Under Hypoxia, V. A. Vorontsov, Ed., Kujbyshev
University Press, 1989, pp. 49-51.
58.
M.M. Seredenko, T.D. Minyailenko (Minko), V. P. Pozharov, E.V. Rozova,
V.K. Lishko, A.V. Stefanov, S.A. Bryginsky, Optimization of respiratory
function during hypoxia by liposomes injection, in: Directions in Optimization
of Respiratory Function Under Exercise, Pathology and Extreme States, I. S.
Breslav, Ed., Kalinin University Press, 1989, pp. 132-137.
59.
T. D. Minyailenko (Minko), V. P. Pozharov, M. M. Seredenko, P. A Radzievsky., N. V.
Shtuchenko, Peculiarities of organism oxygen
supply under bronchial asthma in mountains, in: Usage of Mountain
Climate to Treatment and Prophylaxis, P. V. Beloshitskiy, Ed, Nalchik
University Press, 1988, pp. 42- 46.
60.
V. Ya. Gayday, N. I. Grinenko, E. V. Golobova,
G. A. Borisko, A. Z. Kolchinskaya , T. D. Minyailenko (Minko), E. I. Plehanov, P. A.
Radzievskiy, I. N. Ryzhova, I. F. Sazanchuk, I. G. Sidorenko, M. M. Filippov,
S. H., Cherevatova, N. V. Shtuchenko, Peculiarities of physiological adaptation
in thirteen years old children under exercise and psycho-emotional impacts,
Health Protection of Children and Teenagers, Vol. 2, Zdorov’ya, 1980, pp.
10-14.
61.
Z. Kolchinskaya , Yu.
A. Krupko- Bol’shova, V. A. Antikova, I. B. Vovk, V. P. Dudarev, K. F.
Zhikhareva, A. N. Krasyuk, V. V. Matsinin, T. D. Minyailenko (Minko), P. A. Radzievskiy, N. V.
Shtuchenko, Treatment of patients with secondary anemia by high mountain
climate, in: Molecular Aspects of Adaptation to Hypoxia, A. Z. Kolchinskaya,
Ed., Naukova Dumka, 1979, pp. 238-246.
62.
Z. Kolchinskaya,
V. P. Dudarev, A. G. Misyura, I. N. Man’kovskaya, N. N. Nagnibeda, S. A.
Gulyar, I. F. Sokolyanskiy, V. A. Kozak, I. I. Lanovenko, M. M. Filippov, A. A.
Ivashkevich, V. M. Alekseyev, K. F. Zhikhareva, V. P. Kryzhanoivskiy, T. D.
Minyailenko (Minko), E. V. Lauer, P.
A. Radzievskiy, N. V. Shtuchenko , Yu. V. Strelkov, Characteristics of hypoxic
states, in: Special and Clinical Physiology of Hypoxic States, v.1., A. Z.
Kolchinskaya, Ed., Naukova Dumka, 1979, pp. 16-20.
63.
Yu. A. Krupko-Bol’shova, I. B. Vovk, K. F.
Zhikhareva, V. P. Dudarev, P. V. Baloshitskiy, N. V. Shtuchenko, A. N. Krasyuk,
M. M. Filippov, P. A. Radzievskiy, T. D. Minyailenko (Minko), Threatment of patients with juvenile hemorrhage by the
method of stepwise acclimatization in the high mountain environment, in:
Special and Clinical Physiology of Hypoxic States, v.1., A. Z. Kolchinskaya,
Ed., Naukova Dumka, 1979, pp. 260-263.
64.
T. D.
Minyailenko (Minko),
Peculiarities of blood buffering properties and acid base status in girls with
secondary anemia, in: Special and Clinical Physiology of Hypoxic States, v.1,
A. Z. Kolchinskaya, Ed., Naukova Dumka, 1979, pp. 126-130.
11. T. Minko, A. Kuzmov, R. Savla, O. B.
Garbuzenko, O. Taratula, J. J. Khandare, M. Patil, V. Shah, M. Zhang, K. R.
Reuhl, L. Rodriguez-Rodriguez, Advances in Nanomedicine Applications for
Therapy and Imaging, First International Nanomedicine Symposium and Workshop:
Impact of Nanobiotechnology Applications on the Future of Medicine and
Personalized Medicine, August 4, 2015, Albany, NY.
22.
M. Shah, T. Minko,
Novel formulations of paclitaxel using β-cyclodextrin derivatives as
solubility and permeability enhancers, Annual
Meeting of the American Association of Pharmaceutical Scientists, November
10-14, 2013, San Antonio, TX, W4190.
23.
V. Ivanova, O. B. Garbuzenko, K. R. Reuhl, and T. Minko, Solid lipid nanoparticles
(SLN) for topical pulmonary co-delivery of prostaglandin E and siRNA, Annual Meeting of the American Association of
Pharmaceutical Scientists, November 10-14, 2013, San Antonio, TX, W4011.
24.
M. Dorrani, O. B. Garbuzenko, R. Salva, T. Minko, B. Michniak-Kohn, Lipid nano
particle-based skin delivery of siRNA, Annual
Meeting of the American Association of Pharmaceutical Scientists, November
10-14, 2013, San Antonio, TX, W4051.
25.
J. Praskavich, L. Rodriguez-Rodriguez, T. Minko, Stem cell and mesenchymal
properties correlate with increased L-type voltage gated calcium ion channel
expression in primary and metastatic ovarian carcinoma, Annual Meeting of the American Association of Pharmaceutical
Scientists, November 10-14, 2013, San Antonio, TX, M1396.
26.
R. Savla, O.
Taratula, O. Garbuzenko, V. Shah, T.
Minko, Tumor pH-responsive, mucin-1 targeted quantum dot-doxorubicin
conjugate for imaging and treatment of ovarian cancer, Annual Meeting of the
American Association of Pharmaceutical Scientists, November 10-14, 2013, San
Antonio, TX, W4038.
27.
O.
Taratula, O. B. Garbuzenko, P.
Kirkpatrick, I. Pandya, R. Savla, V. P. Pozharov, H. He, T. Minko, Dendrimer-based multifunctional nanomedicine platforms
for targeted delivery of siRNA, 10th International Nanomedicine and
Drug Delivery (NanoDDS’12) Symposium, December 6-7, 2012, Atlantic City, NJ, P.
42-43.
28.
V.
Ivanova, O. Garbuzenko, K. R. Reuhl, W. Sun, T. Minko, Inhalation treatment of pulmonary fibrosis by liposomal
form of prostaglandin E2, 10th International Nanomedicine and Drug
Delivery (NanoDDS’12) Symposium, December 6-7, 2012, Atlantic City, NJ., #18,
P. 73.
29.
A.
Ghosh, M. Vasanthavada, T. Minko, Development
of solid dispersion formulation by formulation of in-situ amorphous salt using melt extrusion, 10th
International Nanomedicine and Drug Delivery (NanoDDS’12) Symposium, December
6-7, 2012, Atlantic City, NJ., #11, P. 63-64.
30.
A.
Kuzmov, O. Taratula, O. B. Garbizenko, M. Shah, V. Shah, W. Sun, T. Minko, Inhalation delivery of siRNA
and paclitaxel by nanostructured lipid carriers for treatment of lung cancer,
10th International Nanomedicine and Drug Delivery (NanoDDS’12)
Symposium, December 6-7, 2012, Atlantic City, NJ., #24, P. 82-83.
31.
M.
Patel, P. L. Chiu, A. Hemmarine, C. Floristean, A. A. Khoshi, V. Shah, T. Minko, H. He, Direct and rapid
production of monodispersed amphiphilic graphene nanosheets for multifunctional
drug delivery vehicles, 10th International Nanomedicine and Drug
Delivery (NanoDDS’12) Symposium, December 6-7, 2012, Atlantic City, NJ., #32,
P. 94-95.
32.
J.
Praskavich, V. Shah, L. Rodriguez, T.
Minko, Characterization of CACNA1D and CACNA1C L-type voltage-dependent
calcium ion channel expression in sensitive, multidrug resistant and metastatic
ovarian cancer cells, 10th International Nanomedicine and Drug
Delivery (NanoDDS’12) Symposium, December 6-7, 2012, Atlantic City, NJ., #35,
P. 99.
33.
R.
Savla, O. Taratula, O. Garbuzenko, T. Minko, Targeted, pH-responsive
quantum dot-mycin-1-aptamer-doxorubicin conjugates for imaging and treatment of
cancer, 10th International Nanomedicine and Drug Delivery
(NanoDDS’12) Symposium, December 6-7, 2012, Atlantic City, NJ., #39, P. 105.
34.
M. Shah,
V. Shah, T. Minko, Physicochemical
characterization and in vitro
cytotoxicity studies of molecular inclusion complexes of paclitaxel with
β-cyclodextrin derivatives, 10th International Nanomedicine and
Drug Delivery (NanoDDS’12) Symposium, December 6-7, 2012, Atlantic City, NJ.,
#41, P. 108.
35.
V. Shah,
O. Taratula, O. R. Taratula, O. Garbuzenko,
T. Minko, Suppression of CD44
protein and cell death induction in cancer stem cells by utilizing a PPI-based
targeted nanodrug delivery system, 10th International Nanomedicine
and Drug Delivery (NanoDDS’12) Symposium, December 6-7, 2012, Atlantic City,
NJ., #42, P. 109.
36.
J.
Winkler, O. Garbuzenko, T. Minko, M.
S. Tomassone, Synthesis and application of biodegradable Janus particles for
combination therapy, 10th International Nanomedicine and Drug
Delivery (NanoDDS’12) Symposium, December 6-7, 2012, Atlantic City, NJ., #47,
P. 116.
37.
T. Minko, Nanothechnology - Based Targeted Cancer Treatment, Annual
Meeting of the American Association of Pharmaceutical Scientists, October
14-18, 2012, Chicago, IL.
38.
V.
Ivanova, O. B. Garbuzenko, K. R. Reuhl, T.
Minko, Local Inhalation Delivery of Liposomal Prostaglandin E2 for
Treatment of Pulmonary Fibrosis, Annual Meeting of the American
Association of Pharmaceutical Scientists, October 14-18, 2012, Chicago, IL.
39.
A.
Ghosh, M. Vasanthavada, T. Minko,
Dissolution enhancement of a weakly basic drug from its salt solid dispersion
and amorphous dispersions containing acidic counterions, Annual Meeting
of the American Association of Pharmaceutical Scientists, October 14-18, 2012,
Chicago, IL.
40.
M. N.
Shah, V. Shah, T. Minko, Low Molar
Ratio Inclusion Complexes of Paclitaxel With β-Cyclodextrin Derivatives
Suitable for Oral and Intravenous administration, Annual Meeting of the
American Association of Pharmaceutical Scientists, October 14-18, 2012,
Chicago, IL.
41.
J.
Praskavich, V. Shah, L. Rodriguez, T.
Minko, Characterization of CACNA1D Voltage-Dependent Calcium Ion Channel
and CD44 Expression in Primary and Metastatic Ovarian Carcinoma, Annual
Meeting of the American Association of Pharmaceutical Scientists, October 14-18,
2012, Chicago, IL.
42.
V. Shah,
O. Taratula, O. Garbuzenko, T. Minko,
PPi Dendrimer- based nano-drug delivery systems for the simultaneous
suppression of CD44 Protein and Cell death induction in cancer stem cells, Annual
Meeting of the American Association of Pharmaceutical Scientists, October
14-18, 2012, Chicago, IL.
43.
T. Minko, L. Rodriguez-Rodriguez, M. Zhang, O. B. Garbuzenko, V. Shah, O.
Taratula, K. R. Reuhl, Combined Targeted Chemo and Gene Therapy for Tumor
Suppression and Prevention of Metastasis", Oligonucleotide Delivery:
Biology, Engineering and Development, October 8, 2012, Hernstein, Austria.
44.
A.
Kuzmov, M. N Shah, O. Taratula, O. B. Garbuzenko, V. Shah, T. Minko, Targeted Nanostructure Lipid Carriers for Local Delivery
of Drug and siRNA, Pharmacy Research Day, April 17, 2012, Piscataway, NJ, #24.
45.
J. Praskavich,
T. Minko, Contrasting expression of voltage-dependent calcium ion channels
in A2780 drug sensitive ovarian cancer cells and malignant ascites from
patients with advanced ovarian cancer, Annual Meeting of the American
Association of Pharmaceutical Scientists, October 23-27, 2011, Washington, DC, R6049.
46.
M. Zhang, M. L. Patil, O. B. Garbuzenko, T. Minko, Multifunctional triblock
nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and
gene silencing, Annual Meeting of the American Association of Pharmaceutical
Scientists, October 23-27, 2011, Washington, DC, T2061.
47.
V. Shah, O. Taratula, O. Garbuzenko, R. Savla, M.
Zhang, M. Patil, T. Minko, Cyto- and
genotoxicity of different nanocarriers: challenges and approaches, Annual
Meeting of the American Association of Pharmaceutical Scientists, October
23-27, 2011, Washington, DC, M1018.
48.
M. N Shah, A. Kuzmov, O. Taratula, O. Garbuzenko, T.
Minko, Lipid carriers as multifunctional nanomedicine platform for pulmonary
co-delivery of anticancer drugs and siRNA, Annual Meeting of the American
Association of Pharmaceutical Scientists, October 23-27, 2011, Washington, DC,
T3121.
49.
O. Garbuzenko, V. Ivanova, T. Minko, Inhalation treatment of pulmonary fibrosis, Annual
Meeting of the American Association of Pharmaceutical Scientists, October
23-27, 2011, Washington, DC, T2063.
50.
N. Dayan, V. Shah, T.
Minko, Evaluation of the genotoxic potential of whey proteins used for
topical application, Annual Meeting of the American Association of Pharmaceutical
Scientists, October 23-27, 2011, Washington, DC, M1425.
51.
O. Taratula, M. Shah, O. Garbuzenko, T. Minko, Nanostructured lipid carriers
as multifunctional nanomedicine platform for pulmonary co-delivery of
anticancer drugs and siRNA, The 2011 Annual Retreat on Cancer Research in New
Jersey, May 26, 2011, Piscataway, NJ, P16, p. 56.
52.
M. Zhang, O. B. Garbuzenko, K. R. Reuhl, L. Rodriguez, T. Minko, Two-in-one:
Combined targeted chemo and gene therapy for tumor suppression and prevention
of metastases, The 2011 Annual Retreat on Cancer Research in New Jersey, May
26, 2011, Piscataway, NJ, P21, p. 59.
53.
O. Garbuzenko, O. Taratula, T. Minko, The influence of composition, size, and shape of
nanocarriers on their accumulation and retention in lungs after pulmonary (or
inhalatorial) delivery, The 2011 Annual Retreat on Cancer Research in New
Jersey, May 26, 2011, Piscataway, NJ, B2, p. 33.
54.
D. Banerjee, X. Xie, J. E. Kerrigan, T. Minko, A. Scarborough, E.
Ercikan-Abali, T. Budak-Alpdogan, N. Johnson-Farley, K. W. Scotto, J. R.
Bertino, Generation and antitumor effects of a penetratin-peptide that targets
E2F, The 2011 Annual Retreat on Cancer Research in New Jersey, May 26, 2011,
Piscataway, NJ, P2, p. 49.
55.
L. Peddada, A. Joy, D. Devore, O. Garbuzenko, T. Minko, C. M. Roth, Novel carrier for
delivery of antisense therapeutics, The 2011 Annual Retreat on Cancer Research
in New Jersey, May 26, 2011, Piscataway, NJ, P14, p. 55.
56.
M. N. Shah, A. Kuzmov, O. Taratula, O. Garbuzenko, T. Minko, Nanostructured lipid carriers
as multifunctional nanomedicine platform for pulmonary co-delivery of
anticancer drugs and siRNA, Ernest Mario School of Pharmacy Research Day, April
25, 2011, Piscataway, NJ, Abstract #10.
57.
R. Savla, O.Taratula,
O. Garbuzenko, T. Minko, Targeted,
pH-responsive quantum dot-mucin 1 aptamer doxorubicin conjugate for imaging and
treatment of ovarian cancer, Ernest Mario School of Pharmacy Research Day,
April 25, 2011, Piscataway, NJ, Abstract #11.
58.
M. Zhang, O. B. Garbuzenko, K. R. Reuhl, L. Rodriguez, T. Minko, Two-in-one:
Combined targeted chemo and gene therapy for tumor suppression and prevention
of metastases, Ernest Mario School of Pharmacy Research Day, April 25, 2011,
Piscataway, NJ, Abstract #12.
59.
V. V. Shah, T.
Minko, N. Dayan, Evaluation of genotoxicity of a powder and a hydrophilic
polymer using chromosomal aberration assay, Ernest Mario School of Pharmacy
Research Day, April 25, 2011, Piscataway, NJ, Abstract #43.
60.
O. Taratula, O. Garbuzenko, R. Savla, A. Wang, H. He, T. Minko, Multifunctional nanomedicine
platform for cancer specific delivery of siRNA by superparamagnetic iron oxide
nanoparticles-dendrimer complexes, Annual Meeting of the American Association
of Pharmaceutical Scientists, November, 14-18, 2010, New Orleans, LA, T2102.
61.
O. Garbuzenko, O. Taratula, T. Minko, The influence of composition, size, and shape of
nanocarriers on the delivery efficiency to the lungs, Annual Meeting of the
American Association of Pharmaceutical Scientists, November, 14-18, 2010, New
Orleans, LA, M1302.
62.
M. Zhang, O. B. Garbuzenko, K. R. Reuhl, L. Rodriguez-Rodriguez, T.
Minko, Receptor-mediated tumor targeting of drugs with different mechanisms
of action and simultaneous suppression of cellular resistance inhibits tumor
growth and prevents metastases, Annual Meeting of the American Association of
Pharmaceutical Scientists, November, 14-18, 2010, New Orleans, LA, M1044.
63.
V. Shah, T.
Minko, N. Dayan, Evaluation of genotoxicity of a powder and a hydrophilic
polymer using chromosomal aberration assay, Annual Meeting of the American
Association of Pharmaceutical Scientists, November, 14-18, 2010, New Orleans, LA,
W4458.
64.
T. Minko, Nanotechnology
Strategies to Overcome Limitations in Drug Delivery: Opportunities and
Challenges, 8th International Nanomedicine and drug Delivery Symposium,
October, 3-5, 2010, Omaha, NB, p. 24.
65.
T. Minko, Nanotechnology
strategies to overcome limitations in cancer treatment, Particles 2010: Medical/biochemical
diagnostic, pharmaceutical, and drug delivery applications of particle
technology, May, 22-25, 2010, Lake Buena Vista, FL, #100, p. 115-116.
66.
T. Minko,
Nanotechnology strategies to overcome limitations in drug delivery:
Opportunities and challenges, Clinical applications of quantum dot and
nanoparticle technology, UIC Center for Clinical and Translational Science,
April 13, 2010, Chicago, IL, #3.
67.
T. Minko, O.
B. Garbuzenko, M. Saad, K. R. Reuhl, G. Mainelis, New
horizons in treatment of lung cancer: Combinatorial liposomal inhalation
delivery of drugs and suppressors of cellular resistance, Liposome advances:
Recent trends and progress, December 12-15, 2009, London, UK, p.27.
68.
O. Taratula, O. Garbuzenko, Z. Wang, G. Mainelis, T. Minko, Pulmonary co-delivery of
anticancer drug and therapeutic antisense oligonucleotides by mesoporous silica
nanoparticles, Annual Meeting of the American Association of Pharmaceutical
Scientists, November 8-12, 2009, Los Angeles, CA, R6410.
69.
O. Garbuzenko, G. Mainelis, S. Seshadri, T.Minko, Inhalatory vs. Intravenous
Co-Delivery of Anticancer Drugs and Antisense Oligonucleotides/siRNA for Lung
Cancer Treatment, Annual Meeting of the American Association of Pharmaceutical
Scientists, November 8-12, 2009, Los Angeles, CA, R6409.
70.
M. Zhang, O. Garbuzenko, L. Rodriguez, T. Minko, Targeted Combinatorial
Treatment of Ovarian Cancer and Intraperitoneal Metastases, Annual Meeting of
the American Association of Pharmaceutical Scientists, November 8-12, 2009, Los
Angeles, CA, T2249.
71.
L. Shehet, O. Garbuzenko, T. Minko, J. Kohn, Nanospheres-paclitaxel formulation as a
potential anti-caner agent, Annual Meeting of the American Association of
Pharmaceutical Scientists, November 8-12, 2009, Los Angeles, CA, T3373.
72.
Z. Wang, G. Mainelis, O. Taratula, O. Garbuzenko, T. Minko, Anticancer drug pulmonary
delivery by mesoporous silica nanoparticles, The 28th Annual Meeting of the
American Association for Aerosol Research, October 26-30, 2009, Minneapolis,
MN, #1192.
73.
O. Garbuzenko, M. Saad, M. Zhang, E. Ber, A. A.
Vetcher, V. A. Soldatenkov, D. Reimer, T.
Minko, Intratracheal versus intravenous delivery of doxorubicin, antisense
oligonucleotides and siRNA for efficient treatment of lung cancer, The 2009
Annual Retreat on Cancer Research in New Jersey, May 27, 2009, Piscataway, NJ,
P67, p.75.
74.
O. Taratula, O. B. Garbuzenko, P. Kirkpatrick, I.
Pandya, R. Salva, V. P. Pozharov, H. He, T.
Minko, Surface-engineered targeted siRNA-PPI dendrimer complexes for
efficient intracellular and intratumoral delivery, The 2009 Annual Retreat on
Cancer Research in New Jersey, May 27, 2009, Piscataway, NJ, P79, p.81.
75.
M. Zhang, M. L. Patil, O. Taratula, H. He, T. Minko, Surface-modified and
internally cationic polyamidoamine dendrimers for efficient siRNA delivery, The
2009 Annual Retreat on Cancer Research in New Jersey, May 27, 2009, Piscataway,
NJ, P82, p.83.
76.
T. Minko, Nanotechnology
Strategies to Overcome Limitations in Drug Delivery: Opportunities and
Challenges, AAPS Workshop on Evolving Science and Technology in Physical
Pharmacy and Biopharmaceutics, May 13-15, 2009, Baltimore, MD.
77.
O. B. Garbuzenko, T.
Minko, Distribution and retention of anticancer drug, antisense
oligonucleotides and siRNA after their systemic and local liposomal delivery,
The International Nanotechnology Conference, March 30-31, 2009, Jerusalem,
Israel.
78.
S. Seshadri, T. Han, O. Garbuzenko, T. Minko, G. Mainelis, Comparison of
different aerosolization methods used for inhalation delivery of liposomal
drugs in exposure chambers, The 27th Annual Meeting of the American Association
for Aerosol Research, October 20-24, 2008, Orlando, Florida, 3F.02.
79.
S. Betigeri, M. Zhang, O. Garbuzenko, T. Minko, Non-viral nanoscale-based
delivery of antisense oligonucleotides and small interfering RNA targeted to
JNK1 for remediation of cellular hypoxic damage, Annual Meeting of the American
Association of Pharmaceutical Scientists, November 16-20, 2008, Atlanta, GA,
W4031.
80.
M. Saad, O. B. Garbuzenko, E. Ber, P. Chandna, J. J.
Khandare, V. P. Pozharov, T. Minko, Receptor-targeted
nanocarriers for tumor-specific treatment and imaging, Annual Meeting of the
American Association of Pharmaceutical Scientists, November 16-20, 2008,
Atlanta, GA, W4109.
81.
M. Zhang, M. L. Patil, S. Betigeri, O. Taratula, H. He,
T. Minko, Efficient siRNA delivery
systems for cancer therapy: Internally quaternized PAMAM-OH dendrimers, Annual
Meeting of the American Association of Pharmaceutical Scientists, November
16-20, 2008, Atlanta, GA, W4059.
82.
O. Garbuzenko, M. Saad, , M. Zhang, E. Ber, A. A.
Vetcher, V. A. Soldatenkov, D. Reimer, T.
Minko, Intratracheal versus intravenous delivery of doxorubicin, antisense
oligonucleotides and siRNA for efficient treatment of lung cancer, Annual
Meeting of the American Association of Pharmaceutical Scientists, November
16-20, 2008, Atlanta, GA, T3106.
83.
P. Chandna, M. Saad, M. Zhang, O. Garbuzenko, E. Ber, J.
J. Khandare, T. Minko, Design,
synthesis and evaluation of a novel targeted proapoptotic anticancer drug
delivery system for the treatment of different stages of ovarian cancer, Annual
Meeting of the American Association of Pharmaceutical Scientists, November
16-20, 2008, Atlanta, GA, W4095.
84.
M. Zhang, M. L. Patil, S. Betigeri, O. Taratula, H. He,
T. Minko, Internally quaternized
PAMAM-OH dendrimers as efficient siRNA delivery systems for cancer therapy, The
9th New Jersey Symposium on Biomaterials Science and Regenerative
Medicine, October 29-31, 2008, New Brunswick, NJ, #19.
85.
O. Garbuzenko, M. Saad, E. Ber, M. Zhang, T. Minko, Intratracheal versus
intravenous delivery of liposomal Doxorubicin, Antisense oligonucleotides and
siRNA for lung cancer treatment, The 9th New Jersey Symposium on
Biomaterials Science and Regenerative Medicine, October 29-31, 2008, New
Brunswick, NJ, #18.
86.
O. Taratula, R. Savla, I. Pandya, A. Wang, T. Minko, H. He, Targeted co-delivery
of nanoheaters and siRNAs for efficient cancer therapy, 40th Middle Atlantic
Regional Meeting (MARM 2008) of the American Chemical Society, May 17-21.
Bayside, Queens, NY.
87.
O. Taratula, P. Kirkpatrick, R. Savla, I. Pandya, T. Minko, H. He, Layer-by-layer surface
engineering approach for in vivo targeting delivery of siRNA, 40th Middle
Atlantic Regional Meeting (MARM 2008) of the American Chemical Society, May
17-21. Bayside, Queens, NY.
88.
O. Taratula, P. Kirkpatrick, R. Salva, I. Pandya, T. Minko, H. He, Layer-by-layer surface
engineering approach for in vivo targeting delivery of siRNA, ACS National
Meeting August 17-21, 2008, Philadelphia, PA, Abstracts of Papers of the
American Chemical Society, Volume: 236.
89.
O. Taratula, R. Salva, I. Pandya, A. Wang, T. Minko, H. He, Novel SPIO
nanoparticles for a multifunctional nanomedicine platform, ACS National Meeting
August 17-21, 2008, Philadelphia, PA, Abstracts of Papers of the American
Chemical Society, Volume: 236, Meeting Abstract: 70-COLL.
90.
T. Minko, M.
Zhang, M. Saad, O. B. Garbuzenko, M. L. Patil, Efficient Co-Delivery of
siRNA/Antisense Oligonucleotides and Drug for Lung Cancer Treatment, 36th
Annual Scientific Session of the New Jersey Thoracic Society, June 6, 2008, New
Brunswick, NJ, p.4.
91.
P. Chandna, M. Saad, Y. Wang, E. Ber, J. Khandare, A.
A. Vetcher, V. A. Soldatenkov, T. Minko, A novel
targeted proapoptotic anticancer drug delivery system, The Annual Retreat on
Cancer Research in New Jersey, Piscataway, NJ, May 28, 2008, P71, p. 85.
92.
M. Zhang, M. L. Patil, O. Taratula, H. He, T. Minko, Internally quaternized PAMAM-OH
dendrimers as efficient siRNA delivery systems for cancer therapy: The effect
of targeting moiety and degree of quaternization, The Annual Retreat on Cancer
Research in New Jersey, Piscataway, NJ, May 28, 2008, P82, p.90.
93.
M. L. Patil, M. Zhang, S. Betigeri, O. Taratula, H. He,
T. Minko, Modified PAMAM dendrimer
as efficient siRNA delivery system for cancer treatment, The effect of targeting
moiety and degree of quaternization, The Annual Retreat on Cancer Research in
New Jersey, Piscataway, NJ, May 28, 2008, P79, p. 89.
94.
O. Garbuzenko, M. Saad, E. Ber, M. Zhang, A. A.
Vetcher, V. A. Soldatenkov, T. Minko,
Influence of size, charge, shape, and route of liposomes administration on
their cellular uptake, tumor and organ distribution in mice, The Annual Retreat
on Cancer Research in New Jersey, Piscataway, NJ, May 28, 2008, P72, p.85.
95.
M. Saad, O. B. Garbuzenko, J. J. Khandare, Y. Wang, A.
A. Vetcher, V. A. Soldatenkov, T. Minko,
Noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer
research, The Annual Retreat on Cancer Research in New Jersey, Piscataway, NJ,
May 28, 2008, E6, p.43.
96.
O. Taratula, R.Salva, I. Pandya, H. Geng, A. Wang, T. Minko, H. He, Toward a
multifunctional nanomedicine platform for efficient cancer therapy, The Annual
Retreat on Cancer Research in New Jersey, Piscataway, NJ, May 28, 2008, P81,
p.90.
97.
O. Taratula, P. Kirkpatrick, R.Salva, I. Pandya, T. Minko, H. He, Toward in vivo
targeted delivery of siRNA for efficient cancer therapy, The Annual Retreat on
Cancer Research in New Jersey, Piscataway, NJ, May 28, 2008, E5, p.43.
98.
T. Minko, Targeted
multifunctional nanocarriers for tumor treatment and imaging, 2nd
Annual Meeting “Toward the Development of Drug Delivery Systems”, March 7-8,
2008, Perugia, Italy.
99.
P. Chandna, M. Saad, Y. Wang, E. Ber, J. Khandare, A.
A. Vetcher, V. A. Soldatenkov, T. Minko,
A novel targeted proapoptotic anticancer drug delivery system, Annual Meeting
of the American Association of Pharmaceutical Scientists, November 11-15, 2007,
San Diego, CA, M1224.
100. O.
Garbuzenko, M. Saad, E. Ber, M. Zhang, A. A. Vetcher, V. A. Soldatenkov, T. Minko, The influence of liposomal
size on their uptake by cancer cells, tumor and organ distribution in mice
bearing xenografts of human ovarian carcinoma, Annual Meeting of the American
Association of Pharmaceutical Scientists, November 11-15, 2007, San Diego, CA,
T3011.
101. M.
Saad, O. B. Garbuzenko, J. J. Khandare, Y.Wang, A. A. Vetcher, V. A.
Soldatenkov, T. Minko, Noninvasive
In Vivo Bioluminescent and Fluorescent Optical Imaging in Cancer Research,
Annual Meeting of the American Association of Pharmaceutical Scientists,
November 11-15, 2007, San Diego, CA, T2038.
102. S.
Betigeri, O. B. Garbuzenko, T. Minko,
JNK1 as a molecular target to limit cellular damage under hypoxia, Annual
Meeting of the American Association of Pharmaceutical Scientists, November
11-15, 2007, San Diego, CA, T3039.
103. S.
Cai, T. Minko,
D. Discher, Micelles in different morphologies: Advantages of worm-like
filomicelles of PEO-PCL in paclitaxel delivery for lung cancer therapy, Annual
Meeting of the American Association of Pharmaceutical Scientists, November
11-15, 2007, San Diego, CA, W4141.
104. T. Minko, S.Betigeri, E. Ber, P.
Chandna, O. Garbuzenko, J. J. Khandare, R. I. Pakunlu, M. Saad, V. A.
Soldatenkov, M. Zhang, A. A. Vetcher, Y. Wang, Targeted multicomponent
nanocarriers for cancer treatment and diagnostics, The Fifth International
Nanomedicine and Drug Delivery Symposium, November 2-3, 2007, Boston, MA.
105. T. Minko, S.Betigeri, E. Ber, P.
Chandna, O. Garbuzenko, J. J. Khandare, M. Saad, V. A. Soldatenkov, M. Zhang,
A. A. Vetcher, Targeted multicomponent nanocarriers in cancer treatment, The
6th Annual Meeting of the Israeli Chapter of the Controlled Release Society
(ICRS), September 5-6, 2007, Caesarea, Israel, p. 16.
106. O.
Garbuzenko, M. Saad, S.Betigeri, E.
Ber, M. Zhang, A. A. Vetcher, V. A.
Soldatenkov, T. Minko, The influence
of size, charge, shape and route of liposomes administration on their cellular
uptake, tumor and organs distribution in mice with subcutaneous and orthotopic
models of ovarian and lung carcinomas, The 6th Annual Meeting of the Israeli
Chapter of the Controlled Release Society (ICRS), September 5-6, 2007,
Caesarea, Israel, p. 40.
107. T. Minko, O. B. Garbuzenko, M. Saad, Complex
liposomal drug delivery system for inhalatory treatment of lung cancer, 35th
Annual Scientific Session of the New Jersey Thoracic Society, June 1, 2007, New
Brunswick, NJ, p. 5.
108. P.
Chandna, M. Saad, Y. Wang, E. Ber, J. J. Khandare, A. A. Vetcher, V. A.
Soldatenkov, T. Minko, A novel
targeted proapoptotic anticancer drug delivery system, GRASP 2007, 27th
Annual Meeting, New Brunswick, NJ, June 1-3, 2007, pp. 36-37.
109. M.
Saad, J. J. Khandare, Y. Wang, T. Minko,
Noninvasive in vivo bioluminescent and fluorescent optical imaging for cancer
treatment and diagnostics, GRASP 2007, 27th Annual Meeting, New
Brunswick, NJ, June 1-3, 2007, pp. 28-29.
110. O.
Taratula, R. Salva, I. Pandya, A. Wang, T.
Minko, H. He, Multifunctional siRNA delivery system for cancer therapy, GRASP 2007, 27th Annual Meeting,
New Brunswick, NJ, June 1-3, 2007, pp. 33-34.
111. S.
Betigeri, O. B. Garbuzenko, T. Minko,
Efficient liposomal delivery of antisense oligonucleotides and small
interfering RNA targeted to JNK1 for limiting cellular hypoxic damage, GRASP
2007, 27th Annual Meeting, New Brunswick, NJ, June 1-3, 2007, pp.
39-40.
112. Y.
Wang, M. Saad, J. J. Khandare, T. Minko,
In vitro and in vivo evaluation of hypoxia inducible factor antisense
oligonucleotides as an enhancer of antitumor activity, GRASP 2007, 27th
Annual Meeting, New Brunswick, NJ, June 1-3, 2007, p. 53.
113. T. Minko, J. J. Khandare, R. I.
Pakunlu, P. Chandna, M. S. Saad, Y. Wang, LHRH-receptor targeting of polymer
therapeutics and imaging agents to tumor, International Symposium on Polymer
Therapeutics, February 19-21, 2007, Berlin, Germany.
114. P.
Chandna, J. J. Khandare, Y. Wang, T.
Minko, Multivalent targeted polymeric prodrug for cancer therapy, Annual
Meeting of the American Association of Pharmaceutical Scientists, October
29-November 2, 2006, San Antonio, TX, T2087.
115. R.
I. Pakunlu, J. J. Khandare, T. Minko, Modulation of pump and
nonpump cellular resistance in cancer by liposomal antisense oligonucleotides,
Annual Meeting of the American Association of Pharmaceutical Scientists,
October 29-November 2, 2006, San Antonio, TX, W4028.
116. J.
J. Khandare, Y. Wang, S. Jayant, A. Singh, P. Chandna, N. Vorsa, T. Minko, Dendrimers versus peg
polymers: influence of polymer architecture in delivery of paclitaxel for
cancer, Annual Meeting of the American Association of Pharmaceutical
Scientists, October 29-November 2, 2006, San Antonio, TX, T2089.
117. S.
Jayant, J. J. Khandare, T. Minko, Molecular
modeling studies of anticancer prodrugs, Annual Meeting of the American
Association of Pharmaceutical Scientists, October 29-November 2, 2006, San
Antonio, TX, W5100.
118. M.
Saad, J. J. Khandare, Y. Wang, R. I. Pakunlu, T. Minko, Targeted delivery of near-infrared cyanine dye enhances
cancer imaging, Annual Meeting of the American Association of Pharmaceutical
Scientists, October 29-November 2, 2006, San Antonio, TX, T3141.
119. M.
Saad, J. J. Khandare, Y. Wang, T. Minko,
Targeted nanocarier-based delivery of near-infrared cyanine dye enhances tumor
imaging, The Fourth Nanomedicine and Drug Delivery Symposium, October 8-10,
2006, Omaha, NE, p.135.
120. S.
Cai, Y. Geng, T. Minko, D. E.
Discher, Poly(ethylene-oxide)-based worm-like micelles
as potential nanocarriers for delivery of paclitaxel and short antigenic
peptides. The Fourth Nanomedicine and Drug Delivery Symposium, October 8-10,
2006, Omaha, NE, p. 85.
121. T. Minko, R. I. Pakunlu, Y. Wang, Molecular
targeting of drug delivery system to lung cancer, 34th Annual
Scientific Session of New Jersey Thoracic Society, June 2, 2006, New Brunswick,
NJ, p.10.
122. T. Minko, Advanced targeted drug
delivery systems for cancer therapy, International Conference on Advances in
Pharmaceutical Research and Technology, Mumbai, India, November 25-29, 2005, p.
39-40.
123.
S. Dharap, P. Chandna, Y. Wang, B. Qiu, S. Gunaseeian,
P. Sinko, S. Stein, T. Minko,
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide,
Annual Meeting of the American Association of Pharmaceutical Scientists,
November 6-10, 2005, Nashville, TN, #T2080.
124.
R. Pakunlu, J. Khandare, T. Minko, Suppression of tumor cellular resistance by liposomal
antisense oligonucleotides, Annual Meeting of the American Association of
Pharmaceutical Scientists, November 6-10, 2005, Nashville, TN, #T3120.
125.
S. Betigeri, R. I. Pakunlu, Y. Wang, T. Minko, Remediation of cellular
hypoxic damage by antisense oligonucleotides and small interfering RNA Targeted
to JNK1, Annual Meeting of the American
Association of Pharmaceutical Scientists, November 6-10, 2005, Nashville, TN,
#T3047.
126.
J. Khandare, T.
Minko, Polyamidoamine (PAMAM) G4- hydroxyl dendrimer – paclitaxel
nanoconjugates for cancer therapeutics, Annual Meeting of the American
Association of Pharmaceutical Scientists, November 6-10, 2005, Nashville, TN,
#T2144.
127.
Y. Wang, J. Khandare, T. Minko, Hypoxia Inducible factor – targeted polymeric prodrug,
Annual Meeting of the American Association of Pharmaceutical Scientists,
November 6-10, 2005, Nashville, TN, #T3047.
128.
P. Chandna,
J. Khandare, T. Minko, Design,
synthesis and evaluation of targeted multicomponent pegylated anticancer drug
delivery system, Annual Meeting of the American Association of Pharmaceutical
Scientists, November 6-10, 2005, Nashville, TN, #T2138.
129.
F. Ahmed, R. I. Pakunlu, G. Srinivas, M. L. Klein, T. Minko, D. E. Discher, Degradable
polymersomes that create new pathways for anti-cancer drugs, The 2005 Annual
Meeting of American Institute of Chemical Engineers (AIChE), October
30-November 4, 2005, Cincinnati, OH, #489a.
130.
T. Minko, S.
Betigeri, R. I. Pakunlu, Y. Wang, Delivery system for remediation of cellular
hypoxic damage, Third International Nanomedicine and Drug Delivery Symposium,
Baltimore, MD, September 26-27, 2005.
131.
S. Betigeri, R. I. Pakunlu, T. Minko, JNK1 as a molecular target to decrease cellular mortality
under hypoxia, The 25th Anniversary Conference, GRASP 2005, New
York, NY, June 10-12, 2005.
132.
P. Chandna, J. J. Khandare, T. Minko, Design, synthesis and evaluation of targeted
multicomponent pegylated anticancer drug delivery system, The 25th
Anniversary Conference, GRASP 2005, New York, NY, June 10-12, 2005.
133.
R. I. Pakunlu, J. J. Khandare, T. Minko, Modulation of pump and nonpump cellular resistance by
liposomal antisense oligonucleotides, The 25th Anniversary
Conference, GRASP 2005, New York, NY, June 10-12, 2005.
134.
Y. Wang, J. J. Khandare, T. Minko, Inhibition of hypoxia-inducible factor increases the efficacy
of cancer chemotherapy, The 25th Anniversary Conference, GRASP 2005,
New York, NY, June 10-12, 2005.
135.
R. I. Pakunlu, T.
Minko, Modulation of pump and nonpump cellular resistance in cancer, 2005
Annual Retreat on Cancer Research in New Jersey, April 27, 2005, Princeton, NJ,
P86, p. 83.
136.
Y. Wang, J. J. Khandare, T. Minko, 2005 Annual Retreat on Cancer Research in New Jersey,
April 27, 2005, Princeton, NJ, P87, p. 84.
137.
O. Appenzeller, T. Minko, C. Qualls, V. Pozharov, J.
Gamboa, A. Gamboa, R. I. Pakunlu, Cytoprotection in chronic hypoxia in the
Andes; lessons for neurology at sea level. Neurology, 65 A66
Suppl.1, 2005.
138.
O. Appenzeller, T. Minko, C. Qualls, V. Pozharov, J.
Gamboa, A. Gamboa, Y. Wang, An
experiment of nature relevant to ANS function and disease? Neurology, 65 A169
Suppl.1, 2005.
139.
O. Appenzeller, T.
Minko, V. Pozharov, C. Qualls, J. Gamboa, A. Gamboa, Lessons for headache
at sea level? In: High Altitude Medicine & Biology, Abstracts of the 14th
International Hypoxia Symposium, February 22-27, 2005, Chateau Lake Louise,
Alberta, Canada, December 2004, Vol. 5, No. 4: 510-512.
140.
R. I. Pakunlu, Y. Wang, T. Minko, A novel multicomponent delivery system to enhance the
efficacy of lung cancer chemotherapy, Ann. Meeting of the American Association
of Pharmaceutical Scientists, November 7-11, 2004, Baltimore, MD, #T2241.
141.
Y. Wang, R. I. Pakunlu, T. Minko, A novel cancer therapy: combined liposomal hypoxia
inducible factor 1 alpha antisense oligonucleotides and an anticancer drug, Ann.
Meeting of the American Association of Pharmaceutical Scientists, November
7-11, 2004, Baltimore, MD, #T3085.
142. S.
S. Dharap, S. Gunaseelan, B. Qiu, S. Stein, P. J. Sinko, T. Minko, Development of a multicomponent/four tier, targeted,
anticancer drug delivery system, Ann. Meeting of the American Association of
Pharmaceutical Scientists, November 7-11, 2004, Baltimore, MD, #T2066.
143. A.
Lalloo, P. Chao. P. Hu, S-H. Lee, T.
Minko, S. Stein, P. Sinko, Pharmacokinetics and pharmacodynamic evaluation
of topotecan from a novel subcutaneously administered in situ forming hydrogel,
Ann. Meeting of the American Association of Pharmaceutical Scientists, November
7-11, 2004, Baltimore, MD, #T2150.
144.
T. Minko, Extracellular
and Intracellular Molecular Targeting of Drug Delivery System to Cancer Cells,
World Conference on Dosing of Antiinfectivnes – Dosing the Magic Bullets,
September 9-11, 2004, Nurnberg, Germany, #336, p. A-85.
145.
Y. Wang, T.
Minko, Potential use of the combined liposomal hypoxia inducible factor 1
alpha antisense oligonucleotides and doxorubicin as a novel anticancer therapy,
2004 AAPS Pharmaceutics and Drug Delivery Conference, June 7-9, 2004,
Philadelphia, PA, #2003, p.66-67.
146.
S. S. Dharap, S. Gunaseelan, S. Stein, P. J. Sinko, T. Minko, Site specific anticancer
therapy via a four tier drug delivery system, 2004 AAPS Pharmaceutics and Drug
Delivery Conference, June 7-9, 2004, Philadelphia, PA, #2005, p.67-68.
147.
T. Minko, R.
I. Pakunlu, A novel multicomponent delivery system to enhance the efficacy of
lung cancer therapy, 32nd Annual Scientific Section of the New
Jersey Thoracic Society, June 4, 2004, New Brunswick, NJ, #12.
148.
R. I. Pakunlu, Y. Wang, T. Minko, Enhancement of the efficacy of chemotherapy for lung
cancer by simultaneous suppression of multidrug resistance and antiapoptotic
cellular defense: Novel multicomponent delivery system, 24th Annual Meeting of
the Graduate Research Association of Students in Pharmacy (GRASP), June 4-6,
2004, Atlanta, GA, #5.
149.
Y. Wang, R. I. Pakunlu, T. Minko, Potential use of the combined liposomal hypoxia inducible
factor 1 alpha antisense oligonucleotides and doxorubicin as a novel anticancer
therapy, 24th Annual Meeting of the Graduate Research Association of Students
in Pharmacy (GRASP), June 4-6, 2004, Atlanta, GA, #4.
150.
S. S. Dharap, S. Gunaseelan, S. Stein, P. J. Sinko, T. Minko, Site specific anticancer
therapy via a four tier drug delivery system, 24th Annual Meeting of the
Graduate Research Association of Students in Pharmacy (GRASP), June 4-6, 2004,
Atlanta, GA, #37.
151.
Y. Wang, R. I Pakunlu, W. Tsao, T. Minko, Bimodal effect of hypoxia in cancer: the role of hypoxia
inducible factor, Philadelphia Pharmaceutical Forum 2004, March 11,
Philadelphia, PA, p.27.
152.
Y. Wang, T.
Minko, Bimodal effect of hypoxia in cancer: the role of hypoxia inducible
factor, 2003 Annual Meeting of the Division of Bio/Pharmaceutical Sciences
Society of Chinese Bioscientists in America, November 8-9, 2003, Piscataway,
NJ, p. 23.
153.
S. Jin, A. S. Mathis, K. Gioia, T. Minko, G. S. Friedman, J. Rosenblatt, F. Feng, G. T. Knipp, The
effect of sirolimus in combination with cyclosporine on the expression of
macrophage scavenger and nuclear hormone receptors in THP-1 derived human
macrophages, 2003 Annual Meeting of the Division of Bio/Pharmaceutical Sciences
Society of Chinese Bioscientists in America, November 8-9, 2003, Piscataway,
NJ, p. 8.
154.
S. Jin, A. S. Mathis, K. Gioia, T. Minko, G. S. Friedman, F. Feng, G. T. Knipp, The effects of
sirolimus on macrophage scavenger receptors and nuclear receptors in
atherosclerosis, 2003 Annual Meeting of the Division of Bio/Pharmaceutical
Sciences Society of Chinese Bioscientists in America, November 8-9, 2003,
Piscataway, NJ, p. 10.
155.
S. Jin, G. T. Knipp, K. Gioia, T. Minko, G. S. Friedman, J. Rosenblatt, F. Feng, D. S. Serur, A.
S. Mathis, The effect of sirolimus-tacrolimus combination on the expression of
macrophage scavenger and nuclear hormone receptors in THP-1 derived human
macrophages, 2003 Annual Meeting of the Division of Bio/Pharmaceutical Sciences
Society of Chinese Bioscientists in America, November 8-9, 2003, Piscataway, N
J, p.12.
156.
T. Minko,
Molecular targeting of cellular resistance in cancer, 8th World Congress on
Advances in Oncology and 6th International Symposium on Molecular Medicine,
October 16-18, 2003, Hersonissos, Crete, Greece, Int. J. Mol. Med., 12, Sup. 1,
S11, #127 (2003).
157.
S. S. Dharap, B. Qiu, S. Stein, P. J. Sinko, T. Minko, Molecular targeting of proapoptotic
drug delivery systems to cancer by BH3 and LHRH peptides, Ann. Meeting
of the American Association of Pharmaceutical Scientists, October 26-30, 2003,
Salt Lake City, UT, #W5053.
158.
R. I. Pakunlu, T. J. Cook, T. Minko, Novel anticancer drug delivery system for molecular
targeting of pump and non-pump cellular resistance, Ann. Meeting of the
American Association of Pharmaceutical Scientists, October 26-30, 2003, Salt
Lake City, UT, #T2163.
159.
Y. Wang, T.
Minko, Combining hypoxia with chemotherapy in cancer cell treatment -
effects on chemo-resistance and cell death, Ann. Meeting of the American
Association of Pharmaceutical Scientists, October 26-30, 2003, Salt Lake City,
UT, #W5080.
160.
S. Jin, S. A. Mattis, T. Minko, G. T. Knipp, The effects of sirolimus on macrophage
scavenger receptors and nuclear receptors in atherosclerosis, Ann. Meeting of
the American Association of Pharmaceutical Scientists, October 26-30, 2003,
Salt Lake City, UT, #W4077.
161.
S. Jin, S. A. Mattis, T. Minko, G. T. Knipp, The effect of sirolimus in combination with
cyslosporine on the expression of macrophage scavenger and nuclear hormone receptors
in THP-1 derived human macrophages, October 26-30, 2003, Salt Lake City,
UT, #W4078.
162.
S. Jin, S. A. Mattis, T. Minko, G. T. Knipp, The effect of sirolimus in combination with
tacrolimus on the expression of macrophage scavenger and nuclear hormone
receptors in TH-1 derived human macrophages, October 26-30, 2003, Salt Lake
City, UT, #4079.
163.
T. Minko, P.
J. Sinko, T. J. Cook, S. Stein, S. S. Dharap, R. I. Pakunlu, B. Qiu, Molecular
targeting of pump and nonpump cellular resistance in cancer, The 2003 Annual
Retreat on Cancer Research in New Jersey, June 11, 2003, Princeton, NJ, p. 59.
164.
S. S. Dharap, B. Qiu, S. Stein, P. J. Sinko, T. Minko, Molecular targeting of drug
delivery systems to cancer cells by BH3 and LHRH peptides, 23rd Annual Meeting
of the Graduate Research Association of Students in Pharmacy (GRASP), May 30 -
June 1, 2003, Richmond, VA, p. 20.
165.
R. I. Pakunlu, T. J. Cook, T. Minko, Combination of BCL-2 and MDR1/MRP antisense
oligonucleotides and doxorubicin – potential use in cancer therapy, 23rd Annual
Meeting of the Graduate Research Association of Students in Pharmacy (GRASP),
May 30 - June 1, 2003, Richmond, VA, p. 77.
166.
Y. Wang, R. Won, S. Jin, A. S. Mathis, G. T. Knipp, G.
S. Friedman, T. Minko, The effect of
cyclosporine A and tacrolimus on the apoptosis induction and gene expression in
human macrophages, 23rd Annual Meeting of the Graduate Research Association of
Students in Pharmacy (GRASP), May 30 - June 1, 2003, Richmond, VA, p. 82.
167.
S. S. Dharap, B. Qiu, S. Stein, P. Sinko, T. Minko, Targeted Proapoptotic
Anticancer Drug Delivery Systems, Philadelphia Pharmaceutical Forum 2003, March
13th, Philadelphia, PA, p. 15.
168.
R. I. Pakunlu, T. J. Cook, T. Minko, Molecular Targeting of Cellular Resistance in Cancer by
Antisense Oligonucleotides, Philadelphia Pharmaceutical Forum 2003, March 13th,
Philadelphia, PA, p.14.
169.
Y. Wang, R. Won, S. Jin, A. S. Mathis, G. T. Knipp, G.
S. Friedman, T. Minko, Influence of
Immunosuppressors on Apoptosis in Human Macrophages, Philadelphia
Pharmaceutical Forum 2003, March 13th , Philadelphia, PA, p. 11.
170.
T. Minko, P.
J. Sinko, T. J. Cook, S. Stein, S. S. Dharap, R. I. Pakunlu, B. Qiu, Novel
Targeted Drug Delivery Systems Combining Anticancer Drug, Targeting Moiety and
Suppressors of Multidrug Resistance and Antiapoptotic Cellular Defense, CRS
Winter Symposia & 11th International Symposium on Recent Advances in Drug
Delivery Systems, March 3-6, 2003, Salt Lake City, UT, #015.
171.
T. Minko, P.
J. Sinko, T. J. Cook, S. Stein, S. S. Dharap, R. I. Pakunlu, B. Qiu, Molecular
targeting of drug delivery systems to cancer cells by peptides and antisense
oligonucleotides, 2nd International Congress “Molecular
Biopharmaceutics: A New Era in Drug Absorption, Transport and Delivery”,
January 22-24, 2003, Honolulu, HI, p. 98.
172.
P. J. Sinko, S. Stein, T. Minko, M. Leibowitz, Targeted macromolecular drug conjugates for
enhanced cellular uptake, disposition and activity, 2nd
International Congress “Molecular Biopharmaceutics: A New Era in Drug
Absorption, Transport and Delivery”, January 22-24, 2003, Honolulu, HI, p. 26.
173.
S. S. Dharap, T.
Minko, Molecular Targeting of Ovarian Carcinoma Cells Using BH3 and LHRH
Peptides Enhances the Efficacy of Chemotherapy, Ann. Meeting of the American
Association of Pharmaceutical Scientists, November 10-14, 2002, Toronto,
Canada, 2002, W 4054.
174.
R. I. Pakunlu, T. J. Cook, T. Minko, Simultaneous Modulation of Multidrug Resistance and
Antiapoptotic Cellular Defense Using a Combination Drug Delivery System
Containing MDR1 and BCL-2 Targeted Antisense Oligonucleotides, Ann. Meeting of
the American Association of Pharmaceutical Scientists, November 10-14, 2002,
Toronto, Canada, 2002, W 5047.
175. Y.
Wang, R. Won, S. Jin, S. Mathis, G. T. Knipp, G. S. Friedman, T. Minko, Bimodal Effect of
Immunosuppressors on Apoptosis in Human Macrophages, Ann. Meeting of the
American Association of Pharmaceutical Scientists, November 10-14, 2002,
Toronto, Canada, 2002, T 2142.
176. P.
V. Paranjpe, T. Minko, B. Qiu, R.
Won, A. Lalloo, S. Stein, P. J. Sinko, Enhancing the anticancer efficacy of camptothecin
using poly(ethylene glycol) conjugates in human ovarian carcinoma cells, Ann.
Meeting of the American Association of Pharmaceutical Scientists, November
10-14, 2002, Toronto, Canada, 2002, R.
6109.
177.
S. Jin, A. S. Mathis, J. Rosenblatt, T. Minko, G. S. Friedman, K.
Gioia, G. T. Knipp, Additional
investigations into the effect of cyclosporine on macrophage scavenger
receptors regulation associated with atherosclerotic risk, Ann. Meeting of the
American Association of Pharmaceutical Scientists, November 10-14, 2002,
Toronto, Canada, W 4066.
178.
S. Jin, A. S. Mathis, T. Minko, G. S. Friedman, K. Gioia, J. Rosenblatt, G. T. Knipp,
Insights into tacrolimus induced atherosclerotic risk in transplant recipients: macrophage
scavenger receptor regulation, Ann. Meeting of the American Association of
Pharmaceutical Scientists, November 10-14, 2002, Toronto, Canada, T 2143.
179.
T. Minko, P.
J. Sinko, T. J. Cook, S. Stein, Targeted proapoptotic drug delivery systems in
cancer chemotherapy, 7th World Congress on Advances in Oncology and 5th
International Symposium on Molecular Medicine, October 10-12, 2002,
Hersonissos, Crete, Greece, Int. J. Mol. Med., 10, Sup. 1, S10, #124 (2002).
180.
O. Appenzeller, T.
Minko, V. Pozharov, M. Bonfichi, L. Malcovati, L. Bernardi, L. J. Gamboa, Gene
expression in the Andes & autonomics at sea level, 13th International
Symposium On The Autonomic Nervous System, Hilton Head Island, SC, October
24-27, 2002.
181. S.
S. Dharap, T. Minko, Synthetic BCL-2
homology 3 domain (BH3) peptide enhances proapoptotic activity of anticancer
drug doxorubicin, Philadelphia Pharmaceutical Forum 2002, March 14,
Philadelphia, PA, p. 3, 2002.
182. R.
I. Pakunlu, Y. Wang, T. J. Cook, T.
Minko, Suppression of multidrug resistance and antiapoptotic cellular
defense using MDR1- and BCL-2 targeted antisense oligonucleotides and
anticancer drug combination, Philadelphia Pharmaceutical Forum 2002, March 14,
Philadelphia, PA, p. 5, 2002.
183. T. Minko, S. S. Dharap, Enhancing the
efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular
defense, 6th International Symposium “Predictive Oncology and
Intervention Strategies”, 2002, February 9-12, Pasteur Institute, Paris,
France, Cancer Detect. Prevent., 26, S92, 2002.
184. S.
S. Dharap, A. T. Fabbricatore, T. Minko,
Synthetic BCL-2 homology 3 domain (BH3) peptide enhances proapoptotic activity
of doxorubicin, Rutgers Pharmaceutics Conference 2001 “Current and future
issues in dermal drug delivery and pharmaceutics”, East Brunswick, NJ, November
9, 2001.
185. T. Minko, Advanced drug delivery
systems in cancer chemotherapy, Rutgers Pharmaceutics Conference 2001 “Current
and future issues in dermal drug delivery and pharmaceutics”, East Brunswick,
NJ, November 9, 2001.
186. S.
Jin, J. Rosenblatt, S. Mathis, G. Friedman, T. Minko, G. Knipp, Immunosuppressive agents and arteriosclerosis
risk factors, Ann. Meeting of the American Association of Pharmaceutical
Scientists, October, 2001, Denver, CO, AAPS PharmSci., 2001.
187. T. Minko, P. Kopeckova, J. Kopecek,
Caspases-Dependent Apoptosis Signaling Pathways of Free and Polymer-Bound
Doxorubicin in Human Ovarian Carcinoma, Keystone Symposium "Molecular
Mechanisms of Apoptosis", Keystone, CO, January 16-22, 2001, p. 112.
188.
T. Minko, P.
Kopeckova, J. Kopecek, Caspases and Their Role in Signaling Pathways of
Apoptosis Induced by Free and Polymer-Bound Doxorubicin, Ann. Meeting of the
American Association of Pharmaceutical Scientists, October 29-November 2, 2000,
Indianapolis, Indiana, AAPS PharmSci. 2, 2000, Abstract # 4112.
189.
T. Minko, P.
Kopeckova, J. Kopecek, Antitumor activity and apoptosis signaling pathways of
HPMA copolymer-bound doxorubicin, Int. Symposium on Tumor Targeted Delivery
Systems, National Institute of Health, Bethesda, MD, September 25-27, 2000, p.
14.
190.
Y. Kasuya, Z.R. Lu, P. Kopeckova, T. Minko, S. E. Tabibi, J. Kopecek, Synthesis of HPMA
copolymer-bound aminopropylgeldanamycin, Int. Symposium on Tumor Targeted
Delivery Systems, National Institute of Health, Bethesda, MD, September 25-27,
, 2000, p. 17.
191.
W. K. Nichols, T.
Minko, F. T. Lauer, S. W. Burchiel and G. S. Yost, Bioactivated
3-methylyindole (3MI) induces apoptosis in human lung cells, 18th
Annual Meeting of Mountain West Chapter of Society of Toxicology, Snowbird, CO,
September 2000.
192.
T. Minko, P.
Kopeckova, J. Kopecek, Mechanism of anticancer action of HPMA
copolymer-bound doxorubicin, 40th Microsymposium "Polymers in
Medicine", Czech Republic, 2000, Special Lecture #4.
193.
P. Kopeckova, T.
Minko, K. Jensen, J. Kopecek, The influence of cytotoxicity of
macromolecules on the EPR effect in resistant solid tumor, 4th International Symposium on Polymer Therapeutics: from
Laboratory to Clinical Practice, London, UK, 2000, p.53.
194.
T. Minko, P.
Kopeckova, J. Kopecek, Cell death
signaling pathways and antitumor activity of HPMA copolymer-bound adriamycin,
American Association of Pharmaceutical Scientists Annual Meeteng, New Orleans,
LA, 1999, Abstract # 3265, S-436.
195.
M. Demoy, T. Minko, P. Kopeckova, J. Kopecek,
Time and concentration dependent apoptosis induced by free and HPMA
copolymer-bound adriamycin, American
Association of Pharmaceutical Scientists Annual Meeteng, New Orleans, LA, 1999, Abstract # 3264, S-436.
196.
J. Kopecek, P. Kopeckova, T. Minko, Mechanism of action of HPMA copolymer-bound anticancer
drugs, Biosurf III/Annual Meeting of the Swiss Biomaterials Society, Zurich,
Switzerland, 1999, p.13.
197.
T. Minko, P.
Kopeckova, J. Kopecek, Cell death signaling pathways, toxicity and antitumor
activity of free and polymer-bound doxorubucin, “Molecular Genetics in
Toxicology”, 17th Annual Meeting of Mountain West Chapter of Society
of Toxicology, Breckenridge, CO, 1999, Abstract #4
198.
T. Minko, P.
Kopeckova, J. Kopecek, Peculiarities of signaling in apoptosis induced by free
and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells, Keystone Symposia
on Molecular and Cellular Biology, Breckenridge, CO, 1999, p.63.
199.
T. Minko, P Kopeckova,
V. Pozharov, V. Omelyanenko, J. Kopecek, HPMA copolymer bound adriamicyn does
not induce multidrug resistance in a human ovarian cacinoma cell line, 89th
annual Meeting of American Association for Cancer Research, 1998, New Orleans,
LA, p.73.
200.
T. Minko, P.
Kopeckova, V. Pozharov, J. Kopecek, Free and HPMA copolymer bound adriamycin
differ in the mechanism of multidrug resistance induction in a human ovarian
carcinoma cell line, 3rd International Symposium on Polymer Therapeutics: from
Laboratory to Clinical Practice, London, UK, 1998, p. 54.
201.
F. Meerson, V.
Pozharov, T. Minko. Role of heat
shock proteins and phenomenon of adaptive stabilization of structures (PhASS)
in the protection of DNA against ischemic and mutagenic damages.
Physiotherapeutic induction of PhASS, 5th Congress of International Society for
Adaptive Medicine, Boston, MA, 1997, p. 2.
202.
V. Pozharov, T.
Minyailenko (Minko), O. Appenzeller,
A. Stefanov, Hypoxic hypoxia in rats: Circulating and tissue levels of
endothelin: Effects of exogenous phospholipids ("Lipin"), 10 th International Hypoxia Symposium, Lake Louise,
Canada, 1995, p.91.
203.
V. Pozharov, T.
Minyailenko (Minko), O. Appenzeller, Hypoxic hypoxia in rats: Circulating and
tissue levels of endothelin, 10th International Hypoxia Symposium,
Lake Louise, Canada, 1995, p.90.
204.
V. Pozharov, T. Minyailenko (Minko), F. Meerson, Comparative estimation of antihypoxic effects
of adaptation to stress and to high altitude, III World Congress
of ISAM , Tokyo, Japan, 1993, p.
84.
205.
T. Minyailenko (Minko),
V. Pozharov, V. Bystrjukov, F. Meerson, Mechanisms of the increase in
the work load
after preliminary adaptation to
intermittent hypoxia and
training, III World Congress of ISAM , Tokyo, Japan, 1993, p. 76.
206. F.
Z. Meerson, T.D. Minyailenko (Minko),
V. P. Pozharov, Superresistance to hypoxic hypoxia in animals adapted to stress
exposure, III World
Congress of ISAM, Tokyo,
Japan, 1993, p. 72.
207. Stefanov,
V. Pozharov, T. Minyailenko (Minko),
Towards a new way of treating hypoxia, 8th International
Hypoxia Symposium, Lake Louise, Canada, 1993, p. 18.
208.
T. Minyailenko (Minko),
O. Ezhova, Changes in lung phospholipid pattern and compliance during acute
severe hypoxia, 8th International
Hypoxia Symposium, Lake Louise, Canada, 1993, p. 18.
209.
V. Pozharov, T. Minyailenko (Minko), Towards a new
way to elevate
the resistance against
damaging environmental impacts, 1st American –
Ukrainian Workshop "Health
Care: Clinical and Basic Research", Kiev, Ukraine, 1993, p. 4.
210.
V. P. Pozharov,
T. D. Minyailenko (Minko), O. A.
Ezhova, V. R. Tyutyunnik, A. V. Stefanov, Usage of exogenous phospholipids as
liposomes for the protection of heart against hypoxic damage, Physiology and
pathophysiology of heart and coronary blood flow, Kiev, Ukraine, 1992, pp.
131-132.
211.
Z. A. Serebrovskaya, T. D. Minyailenko (Minko), Influence of hypoxic training
on parameters of serum chemolumeniscence and other hematological indices in
human, Actual Aspects of Physiology, Kiev, Ukraine, 1992, pp. 34-35.
212.
A.V. Stefanov, V. P. Pozharov, T. D. Minyailenko (Minko), A.V. Zubarenko, Usage of exogenous phospholipids for the
prevention and treatment of
hypoxic tissue damage, 2nd
International. Symposium. on Hypoxia, Berlin,
Germany, 1991, pp. 75-75a.
213.
T. D. Minyailenko (Minko),
V. P. Pozharov, M. M. Seredenko, Oxygen
supply-consumption ration as the criterion of tissue hypoxia, 2nd International.
Symposium on Hypoxia, Berlin, Germany, 1991, pp. 23-23a.
214.
A.V. Stefanov, V.P. Pozharov, T.D. Minyailenko (Minko), Correction of severe hypoxia
and stress by liposomes, 7th International Hypoxia Symposium, Lake
Louise, Canada, 1991, p. 34.
215.
T. D. Minyailenko (Minko), Hypoxic acid-base
changes, lipid peroxidation and oxygen supply-consumption ratio, 7th
International Hypoxia Symposium, Lake Louise, Canada, 1991, p. 47.
216.
T. D. Minyailenko (Minko),
V. A. Bistryukov, Adaptation to high altitude limits tissue hypoxia and lipid
peroxidation under severe acute environmental hypoxia, International Congress
of Mountain Medicine,
Crans-Montana, Switzerland, 1991, p. 32.
217.
V. Pozharov, T. Minyailenko (Minko), O. Ezhova, V. Bystrjukov, A. Sidorenko, Changes in the respiratory
sensitivity to carbon dioxide under severe hypoxia, 4th
International Symposium on High-Altitude Medicine Science, Matsumoto, Japan
1991, p. 20.
218.
T. Minyailenko (Minko),
V. Pozharov, V. Bystrjukov, O. Ezhova, Adaptation to moderate stress increases
the resistance to severe hypoxia, 4th International Symposium on High-Altitude
Medicine Science, Matsumoto, Japan, 1991, p. 33.
219.
T. Serebrovskaya, G. Afonina, Z. Serebrovskaya, T.
Minyailenko (Minko), Effect of
hypoxic training on human respiration, free radical process and immunity, 4th
International Symposium on High-Altitude
Medicine Science, Matsumoto, Japan, 1991, p. 20.
220.
M. Seredenko, V. Pozharov, T. Minyailenko (Minko), V. Bystrjukov, Energy
metabolism and fatigue, Muscle fatigue: Biochemical and Physiological Aspects, Paris,
France, 1991, p. 248.
221.
T.D. Minyailenko (Minko),
Interrelation of lipid peroxidation and tissue hypoxia under hypoxic states of
different genesis, Constituent Congress of International Society for
Pathophysiology, Moscow, Russia, 1991, pp. 314-315.
222.
V. P. Pozharov, T.D. Minyailenko (Minko), V. A. Bystrjukov, V.R. Tyutyunnik, Peculiarities of
adaptation to exercise in rats with different types of breathing pattern,
Constituent Congress of International Society for Pathophysiology, Moscow,
Russia, 1991, p. 243.
223.
T.D. Minyailenko (Minko),
O. A. Ezhova, Role of lipid peroxidation, changes in organs phospholipid
composition and free fatty acids accululation in the development of secondary
tissue hypoxia, Pharmacological Correction of Hypoxic States, Grodno,
Belorussia, 1991, pp. 449-450.
224.
O. V. Melnik, I. L. Babij, A. V. Zubarenko, T. D.
Minyailenko (Minko), V. P. Pozharov,
B. Ya. Reznik, E. V. Rozova, M. M. Seredenko, A. V. Stefanov, Correction of
hypoxic disturbances under muco-
viscidosis in children, 2nd National Congress of Lung Diseases, Chelyabinsk, Russia, 1991, p.
161.
225.
L. L
Poplavskaya, L. G. Zelinskaya, A. V. Zubarenko, T. D. Minyailenko (Minko), V. P. Pozharov, E. V. Rozova,
M. M. Seredenko, A. V. Stefanov, Phospholipid liposomes in complex therapy
of bronchial asthma in children, 2nd National
Congress of Lung Diseases,
Chelyabinsk, Russia, 1991, p.101.
226.
L. G. Zelinskaya, A. V. Zubarenko, T. D. Minyailenko (Minko), V. P. Pozharov, L. L Poplavskaya, E. V. Rozova, M. M. Seredenko,
A. V. Stefanov, Phospholipid liposomes in complex therapy of chronic pneumonia in children, 2nd
National Congress of Lung Diseases,
Chelyabinsk, Russia, 1991, p. 84.
227.
T. D. Minyailenko (Minko),
Influence of adaptation to high altitude hypoxia on the resistance of an
organism to oxygen deficiency and stress, Functional Reserves and Adaptation,
Kiev, Ukraine, 1990, pp. 88-90.
228.
V. A. Bystrjukov, V. P. Pozharov, T. D. Minyailenko (Minko), V. R. Tyutyunnik, M. M.
Seredenko, Peculiarities of energy supply of working muscles in the rats with
different types of breathing, Structural and Energetic Supply of Mechanical
Muscle Work, Moscow, Russia, 1990, p. 77-78.
229.
M. Seredenko, V. Pozharov, T. Minyailenko (Minko), V. Bystrjukov, Energy metabolism and fatigue,
Biochemical and Physiological Aspects of Muscle Fatigue, Paris, France, 1990,
p. 126.
230.
L. L
Poplavskaya, M. M. Seredenko, T. D. Minyailenko (Minko), V. P. Pozharov, E. V. Rozova, A. V. Stefanov, A. V.
Zubarenko, S. A. Bryginsky, Usage of liposomes in acute period
of bronchial asthma in
children, 1st National
Congress of Lung Diseases, Kiev,
Ukraine, 1990, p. 544.
231.
T. D. Minyailenko (Minko),
V. P. Pozharov, O. A. Ezhova, Phospholipid
pattern of organs and lipid peroxidation during hypoxia, Physiology and Bioenergetics of Hypoxia,
Minsk, Belorussia, 1990, p. 50.
232.
M. M. Seredenko, T. D. Minyailenko (Minko), V. P. Pozharov, E. V
Rozova, Development of hypoxic state in organism during hyperthermia,
System of Thermoregulation During Adaptation of Organism to
Environmental Impacts, Vol. 2,
Novosibirsk, Russia, 1990, p. 211.
233.
V. P. Pozharov, T. D. Minyailenko (Minko), O.A. Ezhova, Factors, which ensure the conformity between
lung gas exchange and metabolism under hypoxia, 13th Congress of
Ukrainian Physiological Society, Kiev, Ukraine, 1990, 2, p. 79.
234.
V. P. Pozharov, T. D. Minyailenko (Minko), M. M. Seredenko, F. Z. Meerson, Disturbances of
respiration and gas exchange under stress and a possibility of its correction,
4th All-Union Congress for Pathophysiology, Vol. 2, Kishinev,
Moldova, 1989, p. 628.
235.
M. M. Seredenko, T. D. Minyailenko (Minko), V. P. Pozharov, O. A. Knish, Oxygen deficiency and lipid
peroxidation in the brain tissue during adaptation to hypoxic impact,
Principles and Mechanisms of Human Brain
Activities, Leningrad, Russia, 1989, p. 137.
236.
T. D. Minyailenko (Minko),
Role of primary disturbances of blood buffer capacity in the compensation of
metabolic acidosis, Actual Problems of Pathology of Respiration, Kujbyshev,
Russia, 1989, pp. 216-217.
237.
L. M. Ulrihina, T. D. Minyailenko (Minko), Hygienic basic for possibilities to use new technology
fish ground products in the nutrition of population, Improvement of
Technological Processes of Manufacturing of New Nutrient Products and
Supplements, Kiev, Ukraine, 1989, p. 53.
238.
M. M. Seredenko, V.
P. Pozharov, T. D. Minyailenko (Minko),
F. Z. Meerson, Mechanisms of hypoxia development under stress,
Ecologo-Physiological Problems of Adaptation, Moscow, Russia, 1988, p. 207.
239.
Z. B. Levinton, Z. B. Rogovaya, T. I. Fliss, A. V.
Kryshevich, T. D. Minyailenko (Minko),
V. P. Pozharov, Experimental basis of possible use of marine food products
under injury of
digestion organs, Modern Digestion
and Illness, Dushanbe,
Tadjikistan, 1988, pp. 274-275.
240.
V. P. Pozharov, T. D. Minyailenko (Minko), Estimation of conformity between brain circulation and
metabolism during hypoxia, Physiology, Phathophysiology and Pharmacology of
Brain Circulation, Tbilisi, Georgia, 1988, p. 147.
241.
T. D. Minyailenko (Minko),
Factors which determine resistance of blood active reaction under hypoxia, in:
Reactivity and Resistance: Fundamental and Applied Aspects, V. A. Antonenko,
Ed., Kiev, Naukova Dumka, 1987, pp. 215-217.
242.
M. M. Seredenko, A. V. Stefanov, V. P. Pozharov, T. D.
Minyailenko (Minko), E. V. Rozova,
S. A. Bryginsky, A. V. Zubarenko, Mechanisms of the increase in the resistance
to hypoxia after the injection of liposomes, in: Reactivity and Resistance:
Fundamental and Applied Aspects, V. A. Antonenko, Ed., Kiev, Naukova Dumka,
1987, pp. 233-235.
243. S.
A. Bryginsky, A. V. Stefanov, M. M. Seredenko, V. P. Pozharov, T. D.
Minyailenko (Minko), E. V. Rozova,
An influence of liposomes on the development of acute hypoxia in animals, 5th Ukrainian Biochemical Congress,
Vol. 1, Kiev, Ukraine 1987, p. 21.
244. V.
Stefanov, V. P. Pozharov, S. A. Bryginsky, V. K. Lishko, M. M. Seredenko, T. D.
Minyailenko (Minko), A. V.
Zubarenko, Influence of liposome incapsulated vitamin E on the development
of hypoxia, Oxygen Regimen, Working
Capacity and Fatigue During Endurance Exercise, Kaunas, Lithuania 1987,
p. 86.
245.
M. M. Seredenko, T. D. Minyailenko (Minko), V. P. Pozharov,
Development of hypoxic
state during endurance exercise in healthy untrained men, Oxygen Regimen,
Working Capacity, Fatigue During Endurance Exercise, Kaunas,
Lithuania. 1987, p. 78.
246.
M. M. Seredenko, E. V. Rozova, T. D. Minyailenko (Minko), V. P. Pozharov, Yu. A.
Krupko-Bolshova, V. F. Peterburgskaya, Peculiarities of the
functional state of an organism oxygen
supply systems in healthy girls and patients with juvenile
bleeding, Problems and Methods of Investigation in Age Physiology, Baku,
Azerbaidjan, 1987, p. 80-81.
247.
M. M. Seredenko, V.
P. Dudarev, I. I. Lanovenko, I. N. Mankovskaya, T. D. Minyailenko (Minko), N. N. Nagnibeda, V. P.
Pozharov, E. V. Rozova, M. M. Filippov, System,
tissue and molecular mechanisms of organism adaptation
to hypoxia of different genesis, 15th Congress of Pavlov
Physiological Society of USSR, Vol. 3,
Leningrad, Russia, 1987, p. 83.
248.
M. M. Seredenko, T. D. Minyailenko (Minko), V. P. Pozharov, P. A. Radzievskiy, N. V. Shtuchenko,
Perculiarities of hemodinamics in healhty subjects and patients with bronchial
asthma during adaptation to high altitude, Circulation in the Conditions of
High Altitude and Experimental Hypoxia, Frunze, Kirgizia, 1986, pp. 156-157.
249.
M. M. Seredenko, T. D. Minyailenko (Minko), V. P. Pozharov, Study of compensation mechanisms of
hypoxic state during hypoxia of different genesis, 12 Congress of Ukrainian
Physiological Society, L’vov, Ukraine,
1986, pp. 365-366.
250.
N. G. Sidoryak, T. D. Minyailenko (Minko), Changes of acid-base status and lactic acid concentration
under methemoglobinemia, 12 Congress of Ukrainian Physiological Society, L’vov, Ukraine, 1986, p.370.
251.
V. P. Dudarev, I. I. Lanovenko, N. N. Nagnibeda, T. D.
Minyailenko (Minko), Mechanisms of
development and compensation of hemic hypoxia in high altitude conditions,
Actual Problems of Modern Physioloigy, Kiev, Ukraine, 1986, pp. 174-175.
252.
T. D. Minyailenko (Minko),
The conformity between oxygen mass transfer and its
consumption during hypoxia of different genesis, Regulation of Respiration and
Gas Mass Transfer in the Organism, Leningrad, Russia, 1985, p. 57.
253.
M. M. Seredenko, T. D. Minyailenko (Minko), V. P. Pozharov, V. P. Rozova, Development of the hypoxic
state during acute graded blood loss, Neural and Humoral Mechanisms of
Compensation During the Action of Pathogenic Factors, Zaporozie, Ukreine, 1985,
p. 122.
254.
P. A. Radzievskiy, T. D. Minyailenko (Minko), Z. R. Yatsenko, Estimation of
organism functional state young and
adult athletes, Problems of Estimation and Prognosis of Organism Functional,
Frunze, Kirgizia, 1984, p. 223.
255.
N. N. Nagnibeda, T. D. Minyailenko (Minko), Influence of hemic hypoxia on sympato-adrenal system and
blood acid-base status, Endocrine System and Damaging Environmental Factors,
Leningad, Russia, 1983, p. 145.
256.
P. A. Radzievskiy, T. D. Minyailenko (Minko), N. V. Shtuchenko, Changes in
respiration, circulation and oxygen regimen of organism under exercise in
trained female 14-15 years old teenagers, Medical Problems of Mass Physical
Culture, Tallin, Estonia, 1983, p. 132.
257.
K. A. Dzintsaradze, T. D. Minyailenko (Minko), Blood buffer properties and
acid-base status in Aphalina dolphin, Control and Rational Usage of Sea
Mammalians, Astrakhan, Russia, 1982, pp. 112-113.
258.
P. A. Beloshitskiy, V. S. Minakov, A. P. Andreeva, A.
G. Reznikov, N. V. Makarenko, P. P. Slin’ko, L. V. Voronina, A. A. Zanchiy, I.
A. Tselnokova, V. I. Voronovskaya, V. Ya. Zhivitsa, T. D. Minyailenko (Minko), P. A. Radzievskiy, N. A.
Shtuchenko, Influence of mountain climate on healthy and suffering from
iron-deficiency anemia arid zone residents, Adaptation of Organisms to
Environment, Syktyvkar, Russia, 1982, p. 120.
259.
I. I. Lanovenko, T. D. Minyailenko (Minko), Disturbances of oxygen mass transfer and metabolism and
their compensation after acute graduated blood lose, 11 Congress of the
Ukrainian Physiological Society, Dnepropetrovsk, Ukraine, 1982, p. 245.
260.
T. D. Minyailenko (Minko),
P. A. Radzievskiy, N. V. Shtuchenko,
Respiration, circulation, blood acid-base balance and oxygen regimen of
organism in women-arid zone lenders with iron deficit anemia under the
influence of mountain climate, Human Adaptation in Different Climatogeographic
and Industrial Environment, Vol. 3, Novosibirsk, Russia, 1981, pp. 155-157.
261.
P. A. Beloshitskiy, V. I. Voronovskaya, V., A. Z.
Kolchinskaya, A. N. Krasyuk, N. V. Makarenko, V. S. Minakov, T. D. Minyailenko (Minko), P. A. Radzievskiy, A. G.
Reznikov, I. S. Tselnokova, N. V. Shtuchenko, Study of functional changes in
iron-deficit anemia arid zone residents during adaptation to high mountain
conditions, Human Adaptation in Different Climatogeographic and Industrial
Environment, Vol. 3, Novosibirsk, Russia, 1981, pp. 154-155.
262.
T. D. Minyailenko (Minko),
P. A. Radzievskiy, N. V. Shtuchenko, Peculiarities of respiration, blood oxygen
transport function, oxygen regimen of organism and blood acid-base equilibrium
in teenagers under hypox hypoxia, Physiological and Clinical Aspects of
Adaptation to Hypoxia, Hypodynamia and Hyperthermia, Vol. 2, Moscow, Russia,
1981, pp. 235-236.
263.
N. N. Sirotinin, A. Z. Kolchinskaya, M. G. Bukhman, I.
I. Girzanich, S. A. Gulyar, V. P. Dudarev, K. F. Jikhareva, A. A. Ivashkevich, M. T. Kerefov, I.
I. Lanovenko, I. N. Man’kovskaya, T. D. Minyailenko (Minko), A. G. Misyura, N. N. Nagnibeda, P. A. Radzievskiy, I. F. Sokolyanskiy, M. M.
Filippov, Hypoxic conditions, their quantitative criteria and ways of
correction, III International Congress for Pathological Physiology, Varna,
Bulgaria, 1978, p. 111.
264.
M. M. Filippov,
P. A. Radzievskiy, T. D. Minyailenko (Minko), Peculiarities of respiration and oxygen transport function
of blood in female teenagers under endurance exercise, 1st All Union
Conference “Physiology of Human Development”, Moscow, Russia, 1977, pp.
179-180.
265.
S. A. Gulyar, M. M. Filippov, V. A. Grinevich, K. D.
Starodub, E. V. Moiseenko, A. S. Spakhov, V. G. Gmyrya, T. D. Minyailenko (Minko), Oxygen mass transfer, carbon
dioxide and inert gases under elevated pressure and exercise, 10th
Congress of Ukrainian Physiological Society, Odessa, Ukraine, 1977, pp.
101-102.